{"schemaVersion":"peptidescanner-evidence-bundle/v1","canonicalUrl":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json","manifestUrl":"https://peptidescanner.com/evidence/v1/manifest.json","peptide":{"slug":"degarelix","name":"Degarelix","url":"https://peptidescanner.com/peptides/degarelix/"},"addressing":"objects is keyed by objectPathId. A URL fragment #<objectPathId> on this file names one evidence object. Every version of a record is placed in the bundle of the record's current first peptide.","objectCount":63,"objects":{"clinicaltrials-gov-nct00116753-degarelix-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct00116753-degarelix:v1","objectPathId":"clinicaltrials-gov-nct00116753-degarelix-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00116753-degarelix/","json":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#clinicaltrials-gov-nct00116753-degarelix-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#clinicaltrials-gov-nct00116753-degarelix-v1"},"story":{"slug":"clinicaltrials-gov-nct00116753-degarelix","version":1,"domain":"Clinical trials","dateInSource":"2010-12-10","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["degarelix"],"peptides":[{"slug":"degarelix","url":"https://peptidescanner.com/peptides/degarelix/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT00116753","sourceIds":["ctg-observation-nct00116753-2010-12-10-ec23a7800445"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT00116753 at 2026-11-15T21:52:09.579Z. Its registry update date was 2010-12-10, and PeptideScanner's reviewed identity mapping was degarelix.","sourceIds":["ctg-observation-nct00116753-2010-12-10-ec23a7800445"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT00116753 at 2026-11-15T21:52:09.579Z. Its registry update date was 2010-12-10, and PeptideScanner's reviewed identity mapping was degarelix.","sourceIds":["ctg-observation-nct00116753-2010-12-10-ec23a7800445"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct00116753-2010-12-10-ec23a7800445"]}],"sources":[{"id":"ctg-observation-nct00116753-2010-12-10-ec23a7800445","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT00116753 · retained source version 2010-12-10:ec23a7800445b6551ca7f9f4244a66195e887827e9f81c287d7fea43c5507769","url":"https://clinicaltrials.gov/study/NCT00116753"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"6faec65d84e5b29e16bda22e13fdf9bde41494a25c8a37c4635645dbeacbcd7a","tierARecordSha256":"96ea071d42e85e3c20bf76f9e9d08cf80310575a3c80a6364b8363c47563df37"},"integrity":{"algorithm":"sha256","contentSha256":"6443b15951141369a35b00a0576792b49ecaeb92894307cc9a2ce551575fdfb9"}},"clinicaltrials-gov-nct00116779-degarelix-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct00116779-degarelix:v1","objectPathId":"clinicaltrials-gov-nct00116779-degarelix-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00116779-degarelix/","json":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#clinicaltrials-gov-nct00116779-degarelix-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#clinicaltrials-gov-nct00116779-degarelix-v1"},"story":{"slug":"clinicaltrials-gov-nct00116779-degarelix","version":1,"domain":"Clinical trials","dateInSource":"2011-12-19","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["degarelix"],"peptides":[{"slug":"degarelix","url":"https://peptidescanner.com/peptides/degarelix/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT00116779","sourceIds":["ctg-observation-nct00116779-2011-12-19-acc2e98bf451"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT00116779 at 2026-11-15T21:52:09.579Z. Its registry update date was 2011-12-19, and PeptideScanner's reviewed identity mapping was degarelix.","sourceIds":["ctg-observation-nct00116779-2011-12-19-acc2e98bf451"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT00116779 at 2026-11-15T21:52:09.579Z. Its registry update date was 2011-12-19, and PeptideScanner's reviewed identity mapping was degarelix.","sourceIds":["ctg-observation-nct00116779-2011-12-19-acc2e98bf451"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct00116779-2011-12-19-acc2e98bf451"]}],"sources":[{"id":"ctg-observation-nct00116779-2011-12-19-acc2e98bf451","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT00116779 · retained source version 2011-12-19:acc2e98bf451934708e145280d4579b582d3cbad3e8d21b79edd253e6ff21c1e","url":"https://clinicaltrials.gov/study/NCT00116779"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"4ce0a45a33fae1b1455860916ae2cd6ee7a40f54b9d78d903091ee48cb3d3d55","tierARecordSha256":"0d83d8deb14efc81ac63ab8a9d04a11cffb471fb280a16840dc517ef6fbe28f2"},"integrity":{"algorithm":"sha256","contentSha256":"a0da9e411a68f2b444bc60b8b9c8ad6c2c10d1a01ecd8d7a1eeba8294ea72b49"}},"clinicaltrials-gov-nct00117286-degarelix-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct00117286-degarelix:v1","objectPathId":"clinicaltrials-gov-nct00117286-degarelix-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00117286-degarelix/","json":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#clinicaltrials-gov-nct00117286-degarelix-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#clinicaltrials-gov-nct00117286-degarelix-v1"},"story":{"slug":"clinicaltrials-gov-nct00117286-degarelix","version":1,"domain":"Clinical trials","dateInSource":"2025-12-18","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["degarelix"],"peptides":[{"slug":"degarelix","url":"https://peptidescanner.com/peptides/degarelix/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT00117286","sourceIds":["ctg-observation-nct00117286-2025-12-18-47931f3554a0"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT00117286 at 2026-11-15T21:52:09.579Z. Its registry update date was 2025-12-18, and PeptideScanner's reviewed identity mapping was degarelix.","sourceIds":["ctg-observation-nct00117286-2025-12-18-47931f3554a0"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT00117286 at 2026-11-15T21:52:09.579Z. Its registry update date was 2025-12-18, and PeptideScanner's reviewed identity mapping was degarelix.","sourceIds":["ctg-observation-nct00117286-2025-12-18-47931f3554a0"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct00117286-2025-12-18-47931f3554a0"]}],"sources":[{"id":"ctg-observation-nct00117286-2025-12-18-47931f3554a0","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT00117286 · retained source version 2025-12-18:47931f3554a00a088ba09ffe7435be35e5c6111e8998a61153dc9d91b061a351","url":"https://clinicaltrials.gov/study/NCT00117286"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"fa56c885a5b926d3c6881b36e214afb7e35ec978251011b9d128203eb1d8ed5e","tierARecordSha256":"2f7472f6f6719ed694e04e040afd29fe4230489f04a2b9be7700332ee75aec5a"},"integrity":{"algorithm":"sha256","contentSha256":"3d12e56c65fe5e161f10b6fc0d7bb1b37963a7ff40ec8dc553c8126537ca8e38"}},"clinicaltrials-gov-nct00117949-degarelix-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct00117949-degarelix:v1","objectPathId":"clinicaltrials-gov-nct00117949-degarelix-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00117949-degarelix/","json":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#clinicaltrials-gov-nct00117949-degarelix-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#clinicaltrials-gov-nct00117949-degarelix-v1"},"story":{"slug":"clinicaltrials-gov-nct00117949-degarelix","version":1,"domain":"Clinical trials","dateInSource":"2011-05-23","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["degarelix"],"peptides":[{"slug":"degarelix","url":"https://peptidescanner.com/peptides/degarelix/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT00117949","sourceIds":["ctg-observation-nct00117949-2011-05-23-81350748b20e"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT00117949 at 2026-11-15T21:52:09.579Z. Its registry update date was 2011-05-23, and PeptideScanner's reviewed identity mapping was degarelix.","sourceIds":["ctg-observation-nct00117949-2011-05-23-81350748b20e"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT00117949 at 2026-11-15T21:52:09.579Z. Its registry update date was 2011-05-23, and PeptideScanner's reviewed identity mapping was degarelix.","sourceIds":["ctg-observation-nct00117949-2011-05-23-81350748b20e"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct00117949-2011-05-23-81350748b20e"]}],"sources":[{"id":"ctg-observation-nct00117949-2011-05-23-81350748b20e","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT00117949 · retained source version 2011-05-23:81350748b20e7b2c0eac2bceabcc765254dc3637b0a92c7827be19e4dc930f78","url":"https://clinicaltrials.gov/study/NCT00117949"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"f87c567bfc78aee89424514bdf65e8092cd55ce8fca64a739d9678364b911e81","tierARecordSha256":"edabc78801cbb901e101a0c43cf758b16ac4126adf9a668104f6c8729f0b96f6"},"integrity":{"algorithm":"sha256","contentSha256":"8984daced565c6551cdb983f391b9937761bf7fe85802c65155eee497f1007f9"}},"clinicaltrials-gov-nct00215683-degarelix-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct00215683-degarelix:v1","objectPathId":"clinicaltrials-gov-nct00215683-degarelix-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00215683-degarelix/","json":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#clinicaltrials-gov-nct00215683-degarelix-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#clinicaltrials-gov-nct00215683-degarelix-v1"},"story":{"slug":"clinicaltrials-gov-nct00215683-degarelix","version":1,"domain":"Clinical trials","dateInSource":"2015-04-01","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["degarelix"],"peptides":[{"slug":"degarelix","url":"https://peptidescanner.com/peptides/degarelix/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT00215683","sourceIds":["ctg-observation-nct00215683-2015-04-01-a49e7874cde3"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT00215683 at 2026-11-15T21:52:09.579Z. Its registry update date was 2015-04-01, and PeptideScanner's reviewed identity mapping was degarelix.","sourceIds":["ctg-observation-nct00215683-2015-04-01-a49e7874cde3"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT00215683 at 2026-11-15T21:52:09.579Z. Its registry update date was 2015-04-01, and PeptideScanner's reviewed identity mapping was degarelix.","sourceIds":["ctg-observation-nct00215683-2015-04-01-a49e7874cde3"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct00215683-2015-04-01-a49e7874cde3"]}],"sources":[{"id":"ctg-observation-nct00215683-2015-04-01-a49e7874cde3","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT00215683 · retained source version 2015-04-01:a49e7874cde308e0298eafa2c8cd6692eb389924bce42c59ae1e92c6b60eb4dc","url":"https://clinicaltrials.gov/study/NCT00215683"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"090e932e093a0b4e4f0215c3dd90e618b7d5bf3358e160bb9cec0eedd74bcb1d","tierARecordSha256":"2580a2da049bed2c53c7e7320a20f6037a6d5c15267a95155d3d63029abb0e23"},"integrity":{"algorithm":"sha256","contentSha256":"9d4d3568eafacf9be923d3e923a16417ce1b30e9064f41547d1139fbe8172381"}},"clinicaltrials-gov-nct00268892-degarelix-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct00268892-degarelix:v1","objectPathId":"clinicaltrials-gov-nct00268892-degarelix-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00268892-degarelix/","json":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#clinicaltrials-gov-nct00268892-degarelix-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#clinicaltrials-gov-nct00268892-degarelix-v1"},"story":{"slug":"clinicaltrials-gov-nct00268892-degarelix","version":1,"domain":"Clinical trials","dateInSource":"2010-12-24","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["degarelix"],"peptides":[{"slug":"degarelix","url":"https://peptidescanner.com/peptides/degarelix/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT00268892","sourceIds":["ctg-observation-nct00268892-2010-12-24-6c93bdac0f75"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT00268892 at 2026-11-15T21:52:09.579Z. Its registry update date was 2010-12-24, and PeptideScanner's reviewed identity mapping was degarelix.","sourceIds":["ctg-observation-nct00268892-2010-12-24-6c93bdac0f75"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT00268892 at 2026-11-15T21:52:09.579Z. Its registry update date was 2010-12-24, and PeptideScanner's reviewed identity mapping was degarelix.","sourceIds":["ctg-observation-nct00268892-2010-12-24-6c93bdac0f75"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct00268892-2010-12-24-6c93bdac0f75"]}],"sources":[{"id":"ctg-observation-nct00268892-2010-12-24-6c93bdac0f75","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT00268892 · retained source version 2010-12-24:6c93bdac0f751ea79f8306583c4f51c275a564f31d79dd3d500d57d33edf7399","url":"https://clinicaltrials.gov/study/NCT00268892"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"90d02f5bb86b4072d609c788520c50b08610aee0d4186f62aa150cba0279d34d","tierARecordSha256":"f006f5d15c327b560773e5edeb1a17b897d80eef574ef69deae98e460b970ed6"},"integrity":{"algorithm":"sha256","contentSha256":"28ec37141daaf8870f061046b715a51f932077a6a0d23df1012aabc7f023996c"}},"clinicaltrials-gov-nct00295750-degarelix-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct00295750-degarelix:v1","objectPathId":"clinicaltrials-gov-nct00295750-degarelix-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00295750-degarelix/","json":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#clinicaltrials-gov-nct00295750-degarelix-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#clinicaltrials-gov-nct00295750-degarelix-v1"},"story":{"slug":"clinicaltrials-gov-nct00295750-degarelix","version":1,"domain":"Clinical trials","dateInSource":"2012-12-19","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["degarelix"],"peptides":[{"slug":"degarelix","url":"https://peptidescanner.com/peptides/degarelix/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT00295750","sourceIds":["ctg-observation-nct00295750-2012-12-19-5b4c6c8c5971"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT00295750 at 2026-11-15T21:52:09.579Z. Its registry update date was 2012-12-19, and PeptideScanner's reviewed identity mapping was degarelix.","sourceIds":["ctg-observation-nct00295750-2012-12-19-5b4c6c8c5971"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT00295750 at 2026-11-15T21:52:09.579Z. Its registry update date was 2012-12-19, and PeptideScanner's reviewed identity mapping was degarelix.","sourceIds":["ctg-observation-nct00295750-2012-12-19-5b4c6c8c5971"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct00295750-2012-12-19-5b4c6c8c5971"]}],"sources":[{"id":"ctg-observation-nct00295750-2012-12-19-5b4c6c8c5971","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT00295750 · retained source version 2012-12-19:5b4c6c8c5971e0878e090443d93c66a1f1cdfea8e76f269f68915270d16d977d","url":"https://clinicaltrials.gov/study/NCT00295750"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"497290a54cbdc61011614c821a30e94f17dc09cfb54e21e25a015d29bc65c540","tierARecordSha256":"8692f9bd4fbed86250f5d32e6f89beeced591b5854e1f0ad1409ddc1a5706dfa"},"integrity":{"algorithm":"sha256","contentSha256":"517961d7deee86581012876a9323e95487ef44953a4a0aa601e818ff9aaeae8d"}},"clinicaltrials-gov-nct00451958-degarelix-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct00451958-degarelix:v1","objectPathId":"clinicaltrials-gov-nct00451958-degarelix-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00451958-degarelix/","json":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#clinicaltrials-gov-nct00451958-degarelix-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#clinicaltrials-gov-nct00451958-degarelix-v1"},"story":{"slug":"clinicaltrials-gov-nct00451958-degarelix","version":1,"domain":"Clinical trials","dateInSource":"2013-03-21","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["degarelix"],"peptides":[{"slug":"degarelix","url":"https://peptidescanner.com/peptides/degarelix/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT00451958","sourceIds":["ctg-observation-nct00451958-2013-03-21-48f2e4e9238e"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT00451958 at 2026-11-15T21:52:09.579Z. Its registry update date was 2013-03-21, and PeptideScanner's reviewed identity mapping was degarelix.","sourceIds":["ctg-observation-nct00451958-2013-03-21-48f2e4e9238e"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT00451958 at 2026-11-15T21:52:09.579Z. Its registry update date was 2013-03-21, and PeptideScanner's reviewed identity mapping was degarelix.","sourceIds":["ctg-observation-nct00451958-2013-03-21-48f2e4e9238e"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct00451958-2013-03-21-48f2e4e9238e"]}],"sources":[{"id":"ctg-observation-nct00451958-2013-03-21-48f2e4e9238e","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT00451958 · retained source version 2013-03-21:48f2e4e9238e4054eb91ddf29aa075bbc0d13c1ced74f28de913fa4493bb7ccd","url":"https://clinicaltrials.gov/study/NCT00451958"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"1d23b90114086fd388a9fdab55827fe25170bb9940f262e3ab1541b03eb4e9cd","tierARecordSha256":"4b1888b3680e8c830bec8e92be511e752af32e2dec21f880bd794d7542217086"},"integrity":{"algorithm":"sha256","contentSha256":"1a976d63377d28db5cf5b5436d4710403834515d72847f11828dbb1d3c08f38a"}},"clinicaltrials-gov-nct00468286-degarelix-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct00468286-degarelix:v1","objectPathId":"clinicaltrials-gov-nct00468286-degarelix-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00468286-degarelix/","json":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#clinicaltrials-gov-nct00468286-degarelix-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#clinicaltrials-gov-nct00468286-degarelix-v1"},"story":{"slug":"clinicaltrials-gov-nct00468286-degarelix","version":1,"domain":"Clinical trials","dateInSource":"2011-03-23","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["degarelix"],"peptides":[{"slug":"degarelix","url":"https://peptidescanner.com/peptides/degarelix/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT00468286","sourceIds":["ctg-observation-nct00468286-2011-03-23-3a08866adc1b"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT00468286 at 2026-11-15T21:52:09.579Z. Its registry update date was 2011-03-23, and PeptideScanner's reviewed identity mapping was degarelix.","sourceIds":["ctg-observation-nct00468286-2011-03-23-3a08866adc1b"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT00468286 at 2026-11-15T21:52:09.579Z. Its registry update date was 2011-03-23, and PeptideScanner's reviewed identity mapping was degarelix.","sourceIds":["ctg-observation-nct00468286-2011-03-23-3a08866adc1b"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct00468286-2011-03-23-3a08866adc1b"]}],"sources":[{"id":"ctg-observation-nct00468286-2011-03-23-3a08866adc1b","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT00468286 · retained source version 2011-03-23:3a08866adc1bd8dd537385ab15c90f8f52440f07021d25e76c9ea699e759197d","url":"https://clinicaltrials.gov/study/NCT00468286"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"0f741790e36161e78b033868f65212b6dc6f359af80a68682f8763f1509641eb","tierARecordSha256":"732f2306417b9e0a2d74fca5ad4a0df3e77141a2ffe904b8989bfe8ba8607863"},"integrity":{"algorithm":"sha256","contentSha256":"57d3e8c66373d6bc41309de072b79e3761ddd891edc8833b3c200c31850ab76b"}},"clinicaltrials-gov-nct00527488-degarelix-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct00527488-degarelix:v1","objectPathId":"clinicaltrials-gov-nct00527488-degarelix-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00527488-degarelix/","json":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#clinicaltrials-gov-nct00527488-degarelix-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#clinicaltrials-gov-nct00527488-degarelix-v1"},"story":{"slug":"clinicaltrials-gov-nct00527488-degarelix","version":1,"domain":"Clinical trials","dateInSource":"2015-05-04","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["degarelix"],"peptides":[{"slug":"degarelix","url":"https://peptidescanner.com/peptides/degarelix/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT00527488","sourceIds":["ctg-observation-nct00527488-2015-05-04-ba3769f2cc26"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT00527488 at 2026-11-15T21:52:09.579Z. Its registry update date was 2015-05-04, and PeptideScanner's reviewed identity mapping was degarelix.","sourceIds":["ctg-observation-nct00527488-2015-05-04-ba3769f2cc26"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT00527488 at 2026-11-15T21:52:09.579Z. Its registry update date was 2015-05-04, and PeptideScanner's reviewed identity mapping was degarelix.","sourceIds":["ctg-observation-nct00527488-2015-05-04-ba3769f2cc26"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct00527488-2015-05-04-ba3769f2cc26"]}],"sources":[{"id":"ctg-observation-nct00527488-2015-05-04-ba3769f2cc26","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT00527488 · retained source version 2015-05-04:ba3769f2cc26cd248a3aad14f00f1297328c62334d34eb1c1db5545c931970be","url":"https://clinicaltrials.gov/study/NCT00527488"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"542a4b7814707b3afc9be8b23c1d606e0523a3097d0db8a9fed1693b5bb02c92","tierARecordSha256":"621a9b5a8b8a5f47b389b578611093d7bd08f9d5df270d2978413e9681fe578c"},"integrity":{"algorithm":"sha256","contentSha256":"41307242886464c1ecc2ca434f5b4b2bb5df77bfe84a5fc029be54ce47ad438d"}},"clinicaltrials-gov-nct00738673-degarelix-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct00738673-degarelix:v1","objectPathId":"clinicaltrials-gov-nct00738673-degarelix-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00738673-degarelix/","json":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#clinicaltrials-gov-nct00738673-degarelix-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#clinicaltrials-gov-nct00738673-degarelix-v1"},"story":{"slug":"clinicaltrials-gov-nct00738673-degarelix","version":1,"domain":"Clinical trials","dateInSource":"2013-01-18","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["degarelix"],"peptides":[{"slug":"degarelix","url":"https://peptidescanner.com/peptides/degarelix/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT00738673","sourceIds":["ctg-observation-nct00738673-2013-01-18-2c5973f3b5aa"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT00738673 at 2026-11-15T21:52:09.579Z. Its registry update date was 2013-01-18, and PeptideScanner's reviewed identity mapping was degarelix.","sourceIds":["ctg-observation-nct00738673-2013-01-18-2c5973f3b5aa"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT00738673 at 2026-11-15T21:52:09.579Z. Its registry update date was 2013-01-18, and PeptideScanner's reviewed identity mapping was degarelix.","sourceIds":["ctg-observation-nct00738673-2013-01-18-2c5973f3b5aa"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct00738673-2013-01-18-2c5973f3b5aa"]}],"sources":[{"id":"ctg-observation-nct00738673-2013-01-18-2c5973f3b5aa","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT00738673 · retained source version 2013-01-18:2c5973f3b5aabb3b65560e4e5e3e6315a400c46930fb4373aa83886648da3f15","url":"https://clinicaltrials.gov/study/NCT00738673"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"5a268af902c4a5d8edc95af0ce21a4fed6cae7782e29679d57df29d523c7833b","tierARecordSha256":"0b5ce09edfd0734794d926ac858b12a1445d47238547eb07305d666763dbc85b"},"integrity":{"algorithm":"sha256","contentSha256":"8c70df9fa4950201f322043f7603a30103c5b975009c93f5f828be7dc413be85"}},"clinicaltrials-gov-nct00801242-degarelix-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct00801242-degarelix:v1","objectPathId":"clinicaltrials-gov-nct00801242-degarelix-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00801242-degarelix/","json":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#clinicaltrials-gov-nct00801242-degarelix-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#clinicaltrials-gov-nct00801242-degarelix-v1"},"story":{"slug":"clinicaltrials-gov-nct00801242-degarelix","version":1,"domain":"Clinical trials","dateInSource":"2014-09-03","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["degarelix"],"peptides":[{"slug":"degarelix","url":"https://peptidescanner.com/peptides/degarelix/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT00801242","sourceIds":["ctg-observation-nct00801242-2014-09-03-623e2cdd2be1"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT00801242 at 2026-11-15T21:52:09.579Z. Its registry update date was 2014-09-03, and PeptideScanner's reviewed identity mapping was degarelix.","sourceIds":["ctg-observation-nct00801242-2014-09-03-623e2cdd2be1"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT00801242 at 2026-11-15T21:52:09.579Z. Its registry update date was 2014-09-03, and PeptideScanner's reviewed identity mapping was degarelix.","sourceIds":["ctg-observation-nct00801242-2014-09-03-623e2cdd2be1"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct00801242-2014-09-03-623e2cdd2be1"]}],"sources":[{"id":"ctg-observation-nct00801242-2014-09-03-623e2cdd2be1","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT00801242 · retained source version 2014-09-03:623e2cdd2be15e34d00a8fd65e38f58882ae4d07e452c506f8fc0531c55c892b","url":"https://clinicaltrials.gov/study/NCT00801242"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"d8db9d0995daca30fb6b968bff340ec467878f6f18c15cfa5ce0e01c8ab1759c","tierARecordSha256":"2cec7cf20961caa2c0e96d692d0cc067d278337f3d52230c7013be495ce324ec"},"integrity":{"algorithm":"sha256","contentSha256":"4140d3ea920571e315ae1829172397aeae6cbfd4959c2d191cdd4af257568510"}},"clinicaltrials-gov-nct00818623-degarelix-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct00818623-degarelix:v1","objectPathId":"clinicaltrials-gov-nct00818623-degarelix-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00818623-degarelix/","json":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#clinicaltrials-gov-nct00818623-degarelix-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#clinicaltrials-gov-nct00818623-degarelix-v1"},"story":{"slug":"clinicaltrials-gov-nct00818623-degarelix","version":1,"domain":"Clinical trials","dateInSource":"2023-11-30","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["degarelix"],"peptides":[{"slug":"degarelix","url":"https://peptidescanner.com/peptides/degarelix/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT00818623","sourceIds":["ctg-observation-nct00818623-2023-11-30-2650a11cf0e2"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT00818623 at 2026-11-15T21:52:09.579Z. Its registry update date was 2023-11-30, and PeptideScanner's reviewed identity mapping was degarelix.","sourceIds":["ctg-observation-nct00818623-2023-11-30-2650a11cf0e2"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT00818623 at 2026-11-15T21:52:09.579Z. Its registry update date was 2023-11-30, and PeptideScanner's reviewed identity mapping was degarelix.","sourceIds":["ctg-observation-nct00818623-2023-11-30-2650a11cf0e2"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct00818623-2023-11-30-2650a11cf0e2"]}],"sources":[{"id":"ctg-observation-nct00818623-2023-11-30-2650a11cf0e2","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT00818623 · retained source version 2023-11-30:2650a11cf0e24d56f93f2231b7e10e2783d31ccc494b2e890078f75d2604ed08","url":"https://clinicaltrials.gov/study/NCT00818623"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"37a3492ec577f54bee4c1ddab222ccb75652e2988b592ce93c1b912cda9b52b6","tierARecordSha256":"aa698c2b0f57bf929d98f74a983b63acdd5eeb4743745708f500153a65d3cc8b"},"integrity":{"algorithm":"sha256","contentSha256":"f4c96faf5b3ffd3e90edaf24da69c7a63e4602219f6f2e659420a40d711957fd"}},"clinicaltrials-gov-nct00819156-degarelix-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct00819156-degarelix:v1","objectPathId":"clinicaltrials-gov-nct00819156-degarelix-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00819156-degarelix/","json":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#clinicaltrials-gov-nct00819156-degarelix-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#clinicaltrials-gov-nct00819156-degarelix-v1"},"story":{"slug":"clinicaltrials-gov-nct00819156-degarelix","version":1,"domain":"Clinical trials","dateInSource":"2023-11-30","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["degarelix"],"peptides":[{"slug":"degarelix","url":"https://peptidescanner.com/peptides/degarelix/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT00819156","sourceIds":["ctg-observation-nct00819156-2023-11-30-d0f9e52ef086"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT00819156 at 2026-11-15T21:52:09.579Z. Its registry update date was 2023-11-30, and PeptideScanner's reviewed identity mapping was degarelix.","sourceIds":["ctg-observation-nct00819156-2023-11-30-d0f9e52ef086"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT00819156 at 2026-11-15T21:52:09.579Z. Its registry update date was 2023-11-30, and PeptideScanner's reviewed identity mapping was degarelix.","sourceIds":["ctg-observation-nct00819156-2023-11-30-d0f9e52ef086"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct00819156-2023-11-30-d0f9e52ef086"]}],"sources":[{"id":"ctg-observation-nct00819156-2023-11-30-d0f9e52ef086","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT00819156 · retained source version 2023-11-30:d0f9e52ef086f374af33386d0d94d174a385ad5f41b72bf5e06f04cff2e76d08","url":"https://clinicaltrials.gov/study/NCT00819156"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"77fac48656a996222bd8718da27fb5245163e4d18aaaf44093718f04cafa5c65","tierARecordSha256":"e64346a60213605e113409b998d15851cf94019d729b16216eefc6a0acae5ce9"},"integrity":{"algorithm":"sha256","contentSha256":"c54b9dcba63011e2a79c62ace8b4686e501f7b9d542cc87f368b612ed2be1dad"}},"clinicaltrials-gov-nct00819247-degarelix-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct00819247-degarelix:v1","objectPathId":"clinicaltrials-gov-nct00819247-degarelix-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00819247-degarelix/","json":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#clinicaltrials-gov-nct00819247-degarelix-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#clinicaltrials-gov-nct00819247-degarelix-v1"},"story":{"slug":"clinicaltrials-gov-nct00819247-degarelix","version":1,"domain":"Clinical trials","dateInSource":"2023-11-09","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["degarelix"],"peptides":[{"slug":"degarelix","url":"https://peptidescanner.com/peptides/degarelix/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT00819247","sourceIds":["ctg-observation-nct00819247-2023-11-09-8f6e3226cb22"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT00819247 at 2026-11-15T21:52:09.579Z. Its registry update date was 2023-11-09, and PeptideScanner's reviewed identity mapping was degarelix.","sourceIds":["ctg-observation-nct00819247-2023-11-09-8f6e3226cb22"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT00819247 at 2026-11-15T21:52:09.579Z. Its registry update date was 2023-11-09, and PeptideScanner's reviewed identity mapping was degarelix.","sourceIds":["ctg-observation-nct00819247-2023-11-09-8f6e3226cb22"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct00819247-2023-11-09-8f6e3226cb22"]}],"sources":[{"id":"ctg-observation-nct00819247-2023-11-09-8f6e3226cb22","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT00819247 · retained source version 2023-11-09:8f6e3226cb22044d88d52506936e839bf47bad9347b022a882276055321a50b0","url":"https://clinicaltrials.gov/study/NCT00819247"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"41f6f67ea7219d5e9ac2977e69f1e5426e3e908e0bd9d47fafbaa830042cbceb","tierARecordSha256":"9d11ad1797192df35dd082586f68f47ccc567c132ece491fc7f679d17bdd2f9e"},"integrity":{"algorithm":"sha256","contentSha256":"f6d473a31dc71557437d9aa6927c4735cc53757915392f4c2ff3973a071ef39a"}},"clinicaltrials-gov-nct00947882-degarelix-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct00947882-degarelix:v1","objectPathId":"clinicaltrials-gov-nct00947882-degarelix-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00947882-degarelix/","json":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#clinicaltrials-gov-nct00947882-degarelix-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#clinicaltrials-gov-nct00947882-degarelix-v1"},"story":{"slug":"clinicaltrials-gov-nct00947882-degarelix","version":1,"domain":"Clinical trials","dateInSource":"2015-06-08","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["degarelix"],"peptides":[{"slug":"degarelix","url":"https://peptidescanner.com/peptides/degarelix/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT00947882","sourceIds":["ctg-observation-nct00947882-2015-06-08-9e91168b09ed"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT00947882 at 2026-11-15T21:52:09.579Z. Its registry update date was 2015-06-08, and PeptideScanner's reviewed identity mapping was degarelix.","sourceIds":["ctg-observation-nct00947882-2015-06-08-9e91168b09ed"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT00947882 at 2026-11-15T21:52:09.579Z. Its registry update date was 2015-06-08, and PeptideScanner's reviewed identity mapping was degarelix.","sourceIds":["ctg-observation-nct00947882-2015-06-08-9e91168b09ed"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct00947882-2015-06-08-9e91168b09ed"]}],"sources":[{"id":"ctg-observation-nct00947882-2015-06-08-9e91168b09ed","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT00947882 · retained source version 2015-06-08:9e91168b09ed96234665f4e89695e9a8b1aab2b2dd3738f4f2fe600b1ebafc09","url":"https://clinicaltrials.gov/study/NCT00947882"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"9f0a783b7bc2d6e329db182d77cd1c6f6deb6a8fa47b661f2205b4a80fd7470d","tierARecordSha256":"b2db6ade728a833ea1aec41cba98310d92974d7912d46c797928606c97fdd398"},"integrity":{"algorithm":"sha256","contentSha256":"9bdc0b58fce452149294db28306c29b47754e0bed947ba879d8c09c2e046b3c0"}},"clinicaltrials-gov-nct00967018-degarelix-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct00967018-degarelix:v1","objectPathId":"clinicaltrials-gov-nct00967018-degarelix-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct00967018-degarelix/","json":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#clinicaltrials-gov-nct00967018-degarelix-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#clinicaltrials-gov-nct00967018-degarelix-v1"},"story":{"slug":"clinicaltrials-gov-nct00967018-degarelix","version":1,"domain":"Clinical trials","dateInSource":"2013-01-03","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["degarelix"],"peptides":[{"slug":"degarelix","url":"https://peptidescanner.com/peptides/degarelix/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT00967018","sourceIds":["ctg-observation-nct00967018-2013-01-03-ec9994d371f1"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT00967018 at 2026-11-15T21:52:09.579Z. Its registry update date was 2013-01-03, and PeptideScanner's reviewed identity mapping was degarelix.","sourceIds":["ctg-observation-nct00967018-2013-01-03-ec9994d371f1"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT00967018 at 2026-11-15T21:52:09.579Z. Its registry update date was 2013-01-03, and PeptideScanner's reviewed identity mapping was degarelix.","sourceIds":["ctg-observation-nct00967018-2013-01-03-ec9994d371f1"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct00967018-2013-01-03-ec9994d371f1"]}],"sources":[{"id":"ctg-observation-nct00967018-2013-01-03-ec9994d371f1","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT00967018 · retained source version 2013-01-03:ec9994d371f150926238ca37ea96bb58edddcc1f9a397e486e70da76201ad44a","url":"https://clinicaltrials.gov/study/NCT00967018"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"f0416c25e7244c431f265cd53b1c6ea4b901cf946b35fd7b07c71767f22876f0","tierARecordSha256":"f6f81730ad1c6fe0b964a448fc69f6e31206bd50affe18952cb5a8325898eddf"},"integrity":{"algorithm":"sha256","contentSha256":"418365debe1c4dd3ac520ea3170be0bc7385f529d89df5c53af17bdfa2bb2dc5"}},"clinicaltrials-gov-nct01071915-degarelix-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct01071915-degarelix:v1","objectPathId":"clinicaltrials-gov-nct01071915-degarelix-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01071915-degarelix/","json":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#clinicaltrials-gov-nct01071915-degarelix-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#clinicaltrials-gov-nct01071915-degarelix-v1"},"story":{"slug":"clinicaltrials-gov-nct01071915-degarelix","version":1,"domain":"Clinical trials","dateInSource":"2013-02-12","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["degarelix"],"peptides":[{"slug":"degarelix","url":"https://peptidescanner.com/peptides/degarelix/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT01071915","sourceIds":["ctg-observation-nct01071915-2013-02-12-a3c702ae8811"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT01071915 at 2026-11-15T21:52:09.579Z. Its registry update date was 2013-02-12, and PeptideScanner's reviewed identity mapping was degarelix.","sourceIds":["ctg-observation-nct01071915-2013-02-12-a3c702ae8811"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT01071915 at 2026-11-15T21:52:09.579Z. Its registry update date was 2013-02-12, and PeptideScanner's reviewed identity mapping was degarelix.","sourceIds":["ctg-observation-nct01071915-2013-02-12-a3c702ae8811"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct01071915-2013-02-12-a3c702ae8811"]}],"sources":[{"id":"ctg-observation-nct01071915-2013-02-12-a3c702ae8811","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT01071915 · retained source version 2013-02-12:a3c702ae881191870a2acc85d5b22b6bf4623fae452d46e0fead8f8147bb02ff","url":"https://clinicaltrials.gov/study/NCT01071915"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"b07dffbd5bf91a8dde6dc5c2dece95698b651acd714e2cfba3ae5d91b5c7b660","tierARecordSha256":"bdf9825f0500afbdb59ad0dd6fc989162919ac6fee2321cbf9f5ddf6c77b048a"},"integrity":{"algorithm":"sha256","contentSha256":"2d022fc34c7160eb58f0ad3ed6546486753b9a95f28f7781acae79b75b7df393"}},"clinicaltrials-gov-nct01215513-degarelix-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct01215513-degarelix:v1","objectPathId":"clinicaltrials-gov-nct01215513-degarelix-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01215513-degarelix/","json":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#clinicaltrials-gov-nct01215513-degarelix-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#clinicaltrials-gov-nct01215513-degarelix-v1"},"story":{"slug":"clinicaltrials-gov-nct01215513-degarelix","version":1,"domain":"Clinical trials","dateInSource":"2013-05-22","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["degarelix"],"peptides":[{"slug":"degarelix","url":"https://peptidescanner.com/peptides/degarelix/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT01215513","sourceIds":["ctg-observation-nct01215513-2013-05-22-bfbb53c4ada5"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT01215513 at 2026-11-15T21:52:09.579Z. Its registry update date was 2013-05-22, and PeptideScanner's reviewed identity mapping was degarelix.","sourceIds":["ctg-observation-nct01215513-2013-05-22-bfbb53c4ada5"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT01215513 at 2026-11-15T21:52:09.579Z. Its registry update date was 2013-05-22, and PeptideScanner's reviewed identity mapping was degarelix.","sourceIds":["ctg-observation-nct01215513-2013-05-22-bfbb53c4ada5"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct01215513-2013-05-22-bfbb53c4ada5"]}],"sources":[{"id":"ctg-observation-nct01215513-2013-05-22-bfbb53c4ada5","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT01215513 · retained source version 2013-05-22:bfbb53c4ada514c613b141ec7b81aa1224e073cc3551eae5f138656998e240a3","url":"https://clinicaltrials.gov/study/NCT01215513"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"28dd5e50b65ee66138a6d6cfffef81f3da778e1d130ced69f5a5e8cd4fc0d90d","tierARecordSha256":"b8a6ef69d626e0e56c42562062a88aa151ba7e831e42d98c94efb35ae1528697"},"integrity":{"algorithm":"sha256","contentSha256":"663592b5eac8ac16c9cdcd6b89a68d8863c2f55d7180f53324bc4435cc56f251"}},"clinicaltrials-gov-nct01220869-degarelix-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct01220869-degarelix:v1","objectPathId":"clinicaltrials-gov-nct01220869-degarelix-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01220869-degarelix/","json":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#clinicaltrials-gov-nct01220869-degarelix-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#clinicaltrials-gov-nct01220869-degarelix-v1"},"story":{"slug":"clinicaltrials-gov-nct01220869-degarelix","version":1,"domain":"Clinical trials","dateInSource":"2025-04-13","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["degarelix"],"peptides":[{"slug":"degarelix","url":"https://peptidescanner.com/peptides/degarelix/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT01220869","sourceIds":["ctg-observation-nct01220869-2025-04-13-659961daf022"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT01220869 at 2026-11-15T21:52:09.579Z. Its registry update date was 2025-04-13, and PeptideScanner's reviewed identity mapping was degarelix.","sourceIds":["ctg-observation-nct01220869-2025-04-13-659961daf022"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT01220869 at 2026-11-15T21:52:09.579Z. Its registry update date was 2025-04-13, and PeptideScanner's reviewed identity mapping was degarelix.","sourceIds":["ctg-observation-nct01220869-2025-04-13-659961daf022"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct01220869-2025-04-13-659961daf022"]}],"sources":[{"id":"ctg-observation-nct01220869-2025-04-13-659961daf022","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT01220869 · retained source version 2025-04-13:659961daf0224d59a2da13ecb0c7ffa1147df38c02719974951769edf0997352","url":"https://clinicaltrials.gov/study/NCT01220869"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"6966edca2e9504ed2a1df7e4c4e7ee2e37027b8f071bdd8f024015801aa0c764","tierARecordSha256":"e811376a95dd4824d041501b513756544f0b28fffb3a057da26dcf900f426f0a"},"integrity":{"algorithm":"sha256","contentSha256":"14a0f73f5455bf632bca5cb5c9f7cfb4ce6c220e9f62144b52822e689409792f"}},"clinicaltrials-gov-nct01696877-degarelix-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct01696877-degarelix:v1","objectPathId":"clinicaltrials-gov-nct01696877-degarelix-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01696877-degarelix/","json":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#clinicaltrials-gov-nct01696877-degarelix-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#clinicaltrials-gov-nct01696877-degarelix-v1"},"story":{"slug":"clinicaltrials-gov-nct01696877-degarelix","version":1,"domain":"Clinical trials","dateInSource":"2019-03-28","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["degarelix"],"peptides":[{"slug":"degarelix","url":"https://peptidescanner.com/peptides/degarelix/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT01696877","sourceIds":["ctg-observation-nct01696877-2019-03-28-72f0c1869e1f"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT01696877 at 2026-11-15T21:52:09.579Z. Its registry update date was 2019-03-28, and PeptideScanner's reviewed identity mapping was degarelix.","sourceIds":["ctg-observation-nct01696877-2019-03-28-72f0c1869e1f"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT01696877 at 2026-11-15T21:52:09.579Z. Its registry update date was 2019-03-28, and PeptideScanner's reviewed identity mapping was degarelix.","sourceIds":["ctg-observation-nct01696877-2019-03-28-72f0c1869e1f"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct01696877-2019-03-28-72f0c1869e1f"]}],"sources":[{"id":"ctg-observation-nct01696877-2019-03-28-72f0c1869e1f","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT01696877 · retained source version 2019-03-28:72f0c1869e1f77d623ef867373d1d2d79705eddce524d3814a4571057d1100b0","url":"https://clinicaltrials.gov/study/NCT01696877"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"9a63fa2029adcd7cec7d2c645191a719382b1b418f9aa93734f4b2195b63d036","tierARecordSha256":"f8d69982116b7fa56c375bb3bd0a5ae59c0b15bdb6627b466651062db98721fc"},"integrity":{"algorithm":"sha256","contentSha256":"80d3c6aa36fce0b8b2b7b29b2a1d287ef91a57d3b083e276dcfe8f880e6926b6"}},"clinicaltrials-gov-nct01731912-degarelix-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct01731912-degarelix:v1","objectPathId":"clinicaltrials-gov-nct01731912-degarelix-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01731912-degarelix/","json":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#clinicaltrials-gov-nct01731912-degarelix-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#clinicaltrials-gov-nct01731912-degarelix-v1"},"story":{"slug":"clinicaltrials-gov-nct01731912-degarelix","version":1,"domain":"Clinical trials","dateInSource":"2019-01-18","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["degarelix"],"peptides":[{"slug":"degarelix","url":"https://peptidescanner.com/peptides/degarelix/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT01731912","sourceIds":["ctg-observation-nct01731912-2019-01-18-c1b684285244"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT01731912 at 2026-11-15T21:52:09.579Z. Its registry update date was 2019-01-18, and PeptideScanner's reviewed identity mapping was degarelix.","sourceIds":["ctg-observation-nct01731912-2019-01-18-c1b684285244"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT01731912 at 2026-11-15T21:52:09.579Z. Its registry update date was 2019-01-18, and PeptideScanner's reviewed identity mapping was degarelix.","sourceIds":["ctg-observation-nct01731912-2019-01-18-c1b684285244"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct01731912-2019-01-18-c1b684285244"]}],"sources":[{"id":"ctg-observation-nct01731912-2019-01-18-c1b684285244","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT01731912 · retained source version 2019-01-18:c1b68428524499a896bbe5026e3a3747b424a68cd63b4f68f08e961c21661d7e","url":"https://clinicaltrials.gov/study/NCT01731912"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"f396e63cc73d905be881f906d78e6a510c33b9c1ee670c51f25ba2848ae85eeb","tierARecordSha256":"fff4b2c34d160012549938bcdc7c96bc1ca84cad0a03f5a6a77402c64b455faf"},"integrity":{"algorithm":"sha256","contentSha256":"b6a9095a6098581e83ede9e7ce20ea0072e3fe86f0b0ba1257e785be9ec74069"}},"clinicaltrials-gov-nct01751451-degarelix-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct01751451-degarelix:v1","objectPathId":"clinicaltrials-gov-nct01751451-degarelix-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct01751451-degarelix/","json":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#clinicaltrials-gov-nct01751451-degarelix-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#clinicaltrials-gov-nct01751451-degarelix-v1"},"story":{"slug":"clinicaltrials-gov-nct01751451-degarelix","version":1,"domain":"Clinical trials","dateInSource":"2021-11-19","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["degarelix"],"peptides":[{"slug":"degarelix","url":"https://peptidescanner.com/peptides/degarelix/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT01751451","sourceIds":["ctg-observation-nct01751451-2021-11-19-d9ff14ad7cc6"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT01751451 at 2026-11-15T21:52:09.579Z. Its registry update date was 2021-11-19, and PeptideScanner's reviewed identity mapping was degarelix.","sourceIds":["ctg-observation-nct01751451-2021-11-19-d9ff14ad7cc6"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT01751451 at 2026-11-15T21:52:09.579Z. Its registry update date was 2021-11-19, and PeptideScanner's reviewed identity mapping was degarelix.","sourceIds":["ctg-observation-nct01751451-2021-11-19-d9ff14ad7cc6"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct01751451-2021-11-19-d9ff14ad7cc6"]}],"sources":[{"id":"ctg-observation-nct01751451-2021-11-19-d9ff14ad7cc6","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT01751451 · retained source version 2021-11-19:d9ff14ad7cc621d9a4022ff57d5e478de0107b2af535b37698cf307ae1bb9c97","url":"https://clinicaltrials.gov/study/NCT01751451"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"989923a9001fa65275fa12f2d0bd7cf98555d8fa1baa69a56a6b30f6605dad7c","tierARecordSha256":"24173cc4968078954d73175162085eb505a7a8b1583879f4cc4254292a0a4b7a"},"integrity":{"algorithm":"sha256","contentSha256":"dfc099c4b04b3141fb1a2dcd7d224ac83d1aca323a27237d79b5b6f6d6217c3b"}},"clinicaltrials-gov-nct02135445-degarelix-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct02135445-degarelix:v1","objectPathId":"clinicaltrials-gov-nct02135445-degarelix-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02135445-degarelix/","json":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#clinicaltrials-gov-nct02135445-degarelix-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#clinicaltrials-gov-nct02135445-degarelix-v1"},"story":{"slug":"clinicaltrials-gov-nct02135445-degarelix","version":1,"domain":"Clinical trials","dateInSource":"2017-04-13","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["degarelix"],"peptides":[{"slug":"degarelix","url":"https://peptidescanner.com/peptides/degarelix/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT02135445","sourceIds":["ctg-observation-nct02135445-2017-04-13-d183caa28fda"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT02135445 at 2026-11-15T21:52:09.579Z. Its registry update date was 2017-04-13, and PeptideScanner's reviewed identity mapping was degarelix.","sourceIds":["ctg-observation-nct02135445-2017-04-13-d183caa28fda"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT02135445 at 2026-11-15T21:52:09.579Z. Its registry update date was 2017-04-13, and PeptideScanner's reviewed identity mapping was degarelix.","sourceIds":["ctg-observation-nct02135445-2017-04-13-d183caa28fda"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct02135445-2017-04-13-d183caa28fda"]}],"sources":[{"id":"ctg-observation-nct02135445-2017-04-13-d183caa28fda","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT02135445 · retained source version 2017-04-13:d183caa28fda9f981d12a44328a56ae552b371d2f78511074be69c808d17d967","url":"https://clinicaltrials.gov/study/NCT02135445"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"2627bcb67a4a0762c5fafccc8136954af3fb058daa5982fe3ae73dae29ca2f0b","tierARecordSha256":"d1b83f273f7c0be66807e32d71fa32e554e6e86b90a105f1a96cbd8872acf193"},"integrity":{"algorithm":"sha256","contentSha256":"d907761e33758a7ac579f97147c6ae17a67d43baf9d77cc1cd0effbb0faf716a"}},"clinicaltrials-gov-nct02489357-degarelix-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct02489357-degarelix:v1","objectPathId":"clinicaltrials-gov-nct02489357-degarelix-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02489357-degarelix/","json":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#clinicaltrials-gov-nct02489357-degarelix-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#clinicaltrials-gov-nct02489357-degarelix-v1"},"story":{"slug":"clinicaltrials-gov-nct02489357-degarelix","version":1,"domain":"Clinical trials","dateInSource":"2021-11-12","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["degarelix"],"peptides":[{"slug":"degarelix","url":"https://peptidescanner.com/peptides/degarelix/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT02489357","sourceIds":["ctg-observation-nct02489357-2021-11-12-edeb25c5bb91"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT02489357 at 2026-11-15T21:52:09.579Z. Its registry update date was 2021-11-12, and PeptideScanner's reviewed identity mapping was degarelix.","sourceIds":["ctg-observation-nct02489357-2021-11-12-edeb25c5bb91"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT02489357 at 2026-11-15T21:52:09.579Z. Its registry update date was 2021-11-12, and PeptideScanner's reviewed identity mapping was degarelix.","sourceIds":["ctg-observation-nct02489357-2021-11-12-edeb25c5bb91"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct02489357-2021-11-12-edeb25c5bb91"]}],"sources":[{"id":"ctg-observation-nct02489357-2021-11-12-edeb25c5bb91","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT02489357 · retained source version 2021-11-12:edeb25c5bb91158b6d5e704f333f587d496142f43f52abd3a32ee8bcc60b3164","url":"https://clinicaltrials.gov/study/NCT02489357"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"f7842cce7f75b7d5606a0ad92a12d4bae544a66d8c47920ce2f8bd2ab388aa73","tierARecordSha256":"8c59b42d09f7435e39add9a2f5d66d48a5f7e6b9ee48c6c33e450d13d75b2974"},"integrity":{"algorithm":"sha256","contentSha256":"17d32b23e66dfae26beccebba8e9bad215443a8b01cc519d278dd1098bda31ed"}},"clinicaltrials-gov-nct02849990-degarelix-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct02849990-degarelix:v1","objectPathId":"clinicaltrials-gov-nct02849990-degarelix-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02849990-degarelix/","json":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#clinicaltrials-gov-nct02849990-degarelix-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#clinicaltrials-gov-nct02849990-degarelix-v1"},"story":{"slug":"clinicaltrials-gov-nct02849990-degarelix","version":1,"domain":"Clinical trials","dateInSource":"2022-01-13","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["degarelix"],"peptides":[{"slug":"degarelix","url":"https://peptidescanner.com/peptides/degarelix/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT02849990","sourceIds":["ctg-observation-nct02849990-2022-01-13-960491ed67e7"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT02849990 at 2026-11-15T21:52:09.579Z. Its registry update date was 2022-01-13, and PeptideScanner's reviewed identity mapping was degarelix.","sourceIds":["ctg-observation-nct02849990-2022-01-13-960491ed67e7"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT02849990 at 2026-11-15T21:52:09.579Z. Its registry update date was 2022-01-13, and PeptideScanner's reviewed identity mapping was degarelix.","sourceIds":["ctg-observation-nct02849990-2022-01-13-960491ed67e7"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct02849990-2022-01-13-960491ed67e7"]}],"sources":[{"id":"ctg-observation-nct02849990-2022-01-13-960491ed67e7","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT02849990 · retained source version 2022-01-13:960491ed67e77106fdf3240a92a532f089161648263c59cdfb3c0847a12a6be5","url":"https://clinicaltrials.gov/study/NCT02849990"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"6ba7756719fb93b5872c1dd271bdb3b478840121cff308328db70c84ae9acfe6","tierARecordSha256":"67ef9919c3450c41139c12def251c978b36bac87d1d9cb3941682554b8e170a6"},"integrity":{"algorithm":"sha256","contentSha256":"94db65506bdc50b6fade69ed5a6c877f05de01739d599f4951838d3dfc6ae284"}},"clinicaltrials-gov-nct03069937-degarelix-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct03069937-degarelix:v1","objectPathId":"clinicaltrials-gov-nct03069937-degarelix-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct03069937-degarelix/","json":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#clinicaltrials-gov-nct03069937-degarelix-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#clinicaltrials-gov-nct03069937-degarelix-v1"},"story":{"slug":"clinicaltrials-gov-nct03069937-degarelix","version":1,"domain":"Clinical trials","dateInSource":"2025-10-15","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["degarelix"],"peptides":[{"slug":"degarelix","url":"https://peptidescanner.com/peptides/degarelix/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT03069937","sourceIds":["ctg-observation-nct03069937-2025-10-15-1f86016aa7fb"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT03069937 at 2026-11-15T21:52:09.579Z. Its registry update date was 2025-10-15, and PeptideScanner's reviewed identity mapping was degarelix.","sourceIds":["ctg-observation-nct03069937-2025-10-15-1f86016aa7fb"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT03069937 at 2026-11-15T21:52:09.579Z. Its registry update date was 2025-10-15, and PeptideScanner's reviewed identity mapping was degarelix.","sourceIds":["ctg-observation-nct03069937-2025-10-15-1f86016aa7fb"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct03069937-2025-10-15-1f86016aa7fb"]}],"sources":[{"id":"ctg-observation-nct03069937-2025-10-15-1f86016aa7fb","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT03069937 · retained source version 2025-10-15:1f86016aa7fbc65d5cf7dd1da4dcdcac3f5b692b3b64e2e292be895c0605ec94","url":"https://clinicaltrials.gov/study/NCT03069937"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"759e847413ed614faaf4fb3ed546cd98795ed9f3c42ae078565a2eb15cae6799","tierARecordSha256":"cfe0c8a5788ceecf37eaeb60836e3b62775e1ded5f38dd1b2ba80fc6e0298221"},"integrity":{"algorithm":"sha256","contentSha256":"31b87a4d23499c4e05924776d7258d7a570a0d647c3a6cfb1f32df51c24e4771"}},"clinicaltrials-gov-nct03689699-degarelix-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct03689699-degarelix:v1","objectPathId":"clinicaltrials-gov-nct03689699-degarelix-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct03689699-degarelix/","json":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#clinicaltrials-gov-nct03689699-degarelix-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#clinicaltrials-gov-nct03689699-degarelix-v1"},"story":{"slug":"clinicaltrials-gov-nct03689699-degarelix","version":1,"domain":"Clinical trials","dateInSource":"2026-10-15","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["degarelix"],"peptides":[{"slug":"degarelix","url":"https://peptidescanner.com/peptides/degarelix/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT03689699","sourceIds":["ctg-observation-nct03689699-2026-10-15-71a398c43021"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT03689699 at 2026-11-15T21:52:09.579Z. Its registry update date was 2026-10-15, and PeptideScanner's reviewed identity mapping was degarelix.","sourceIds":["ctg-observation-nct03689699-2026-10-15-71a398c43021"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT03689699 at 2026-11-15T21:52:09.579Z. Its registry update date was 2026-10-15, and PeptideScanner's reviewed identity mapping was degarelix.","sourceIds":["ctg-observation-nct03689699-2026-10-15-71a398c43021"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct03689699-2026-10-15-71a398c43021"]}],"sources":[{"id":"ctg-observation-nct03689699-2026-10-15-71a398c43021","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT03689699 · retained source version 2026-10-15:71a398c43021ee18d38d444168ce9d0019276f741c3922161a2f6aedd323b859","url":"https://clinicaltrials.gov/study/NCT03689699"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"58db0f7b79753620d6719efe12b916c82a2cc84f55b0eade9c6c44a696622eea","tierARecordSha256":"44f8e272b71a9439407deecc46b77a5d948fc40462459bb94426252039312894"},"integrity":{"algorithm":"sha256","contentSha256":"827bbdd0826aa50a5ba5d4b19394f0f9aee4e53b12f345980d52c6530b157f44"}},"clinicaltrials-gov-nct04397718-degarelix-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct04397718-degarelix:v1","objectPathId":"clinicaltrials-gov-nct04397718-degarelix-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct04397718-degarelix/","json":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#clinicaltrials-gov-nct04397718-degarelix-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#clinicaltrials-gov-nct04397718-degarelix-v1"},"story":{"slug":"clinicaltrials-gov-nct04397718-degarelix","version":1,"domain":"Clinical trials","dateInSource":"2022-06-06","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["degarelix"],"peptides":[{"slug":"degarelix","url":"https://peptidescanner.com/peptides/degarelix/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT04397718","sourceIds":["ctg-observation-nct04397718-2022-06-06-151319ceda16"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT04397718 at 2026-11-15T21:52:09.579Z. Its registry update date was 2022-06-06, and PeptideScanner's reviewed identity mapping was degarelix.","sourceIds":["ctg-observation-nct04397718-2022-06-06-151319ceda16"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT04397718 at 2026-11-15T21:52:09.579Z. Its registry update date was 2022-06-06, and PeptideScanner's reviewed identity mapping was degarelix.","sourceIds":["ctg-observation-nct04397718-2022-06-06-151319ceda16"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct04397718-2022-06-06-151319ceda16"]}],"sources":[{"id":"ctg-observation-nct04397718-2022-06-06-151319ceda16","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT04397718 · retained source version 2022-06-06:151319ceda16ae85b92c4f761da4f92335922e3366cfb983f3fc81bbf236a280","url":"https://clinicaltrials.gov/study/NCT04397718"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"0ceba95d59cd58086b8411c5faf2757668cb5e5e93533d2f31cd7021982f1bae","tierARecordSha256":"da6945342865ec8f9844fffa74241ee7a64aac071ee112b0e7cbc01a194a6c7e"},"integrity":{"algorithm":"sha256","contentSha256":"94294fa4a655c3788474b96b0ef7c7e6325a9b91a13de5da952b0bbfcbfb3746"}},"clinicaltrials-gov-nct05181800-degarelix-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct05181800-degarelix:v1","objectPathId":"clinicaltrials-gov-nct05181800-degarelix-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct05181800-degarelix/","json":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#clinicaltrials-gov-nct05181800-degarelix-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#clinicaltrials-gov-nct05181800-degarelix-v1"},"story":{"slug":"clinicaltrials-gov-nct05181800-degarelix","version":1,"domain":"Clinical trials","dateInSource":"2024-09-27","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["degarelix"],"peptides":[{"slug":"degarelix","url":"https://peptidescanner.com/peptides/degarelix/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT05181800","sourceIds":["ctg-observation-nct05181800-2024-09-27-7af527723cd2"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT05181800 at 2026-11-15T21:52:09.579Z. Its registry update date was 2024-09-27, and PeptideScanner's reviewed identity mapping was degarelix.","sourceIds":["ctg-observation-nct05181800-2024-09-27-7af527723cd2"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT05181800 at 2026-11-15T21:52:09.579Z. Its registry update date was 2024-09-27, and PeptideScanner's reviewed identity mapping was degarelix.","sourceIds":["ctg-observation-nct05181800-2024-09-27-7af527723cd2"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct05181800-2024-09-27-7af527723cd2"]}],"sources":[{"id":"ctg-observation-nct05181800-2024-09-27-7af527723cd2","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT05181800 · retained source version 2024-09-27:7af527723cd26a5b25495646d8b25d05c83c4ce0548470f26d38c80e8e4232a3","url":"https://clinicaltrials.gov/study/NCT05181800"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"a70c1823236a30fda4bf36cc0fbfb38c6646da95a000bc03e96d4270ba398976","tierARecordSha256":"561b3184af73d2b4a7322baf0ab9f0d75a3950d96e446b482d9ace6c93d90458"},"integrity":{"algorithm":"sha256","contentSha256":"e6faade9ea24a4fbb9bbeae54c0df08a1d738265b1166e51ba535caeb4cf4bdb"}},"fda-drugs-nda022201-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:fda-drugs-nda022201:v1","objectPathId":"fda-drugs-nda022201-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/fda-drugs-nda022201/","json":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#fda-drugs-nda022201-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#fda-drugs-nda022201-v1"},"story":{"slug":"fda-drugs-nda022201","version":1,"domain":"Regulatory","dateInSource":"2008-12-24","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["degarelix"],"peptides":[{"slug":"degarelix","url":"https://peptidescanner.com/peptides/degarelix/"}]},"claims":[{"id":"headline","text":"Drugs@FDA application NDA022201","sourceIds":["fda-drugs-nda022201-2008-12-24-99604c7c3fa8"]},{"id":"summary","text":"The official Drugs@FDA dataset lists original submission 1 for NDA 022201 with status AP dated 2008-12-24, and names degarelix acetate among the application record's active ingredients.","sourceIds":["fda-drugs-nda022201-2008-12-24-99604c7c3fa8"]},{"id":"paragraph-1","text":"The official Drugs@FDA dataset lists original submission 1 for NDA 022201 with status AP dated 2008-12-24, and names degarelix acetate among the application record's active ingredients.","sourceIds":["fda-drugs-nda022201-2008-12-24-99604c7c3fa8"]},{"id":"paragraph-2","text":"This page reports bounded application metadata attributed to Drugs@FDA. It does not reproduce labeling, describe an indication, compare products, or provide medical guidance.","sourceIds":["fda-drugs-nda022201-2008-12-24-99604c7c3fa8"]}],"sources":[{"id":"fda-drugs-nda022201-2008-12-24-99604c7c3fa8","name":"Drugs@FDA via openFDA","sourceClass":"A","title":"Drugs@FDA application NDA022201 · original submission status AP · 2008-12-24 · dataset 2026-11-13","url":"https://api.fda.gov/drug/drugsfda.json?search=application_number%3A%22NDA022201%22&limit=1"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"740793e5491cd1ee15c85e5f22b47be2942c2274c05d258433413c58ac1aa92b","tierARecordSha256":"99604c7c3fa8edfd35f1bf795c29da94fa23735554d665c6d9d13dcc9ae39786"},"integrity":{"algorithm":"sha256","contentSha256":"a159727ce7f20025e1afe8d2c6611b79d8e5d77d1378c64a5460ded48073a9e1"}},"federal-register-2010-4159-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:federal-register-2010-4159:v1","objectPathId":"federal-register-2010-4159-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/federal-register-2010-4159/","json":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#federal-register-2010-4159-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#federal-register-2010-4159-v1"},"story":{"slug":"federal-register-2010-4159","version":1,"domain":"Regulatory","dateInSource":"2010-03-01","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["degarelix"],"peptides":[{"slug":"degarelix","url":"https://peptidescanner.com/peptides/degarelix/"}]},"claims":[{"id":"headline","text":"Federal Register notice 2010-4159","sourceIds":["federal-register-2010-4159-840a1c77b7d2"]},{"id":"summary","text":"The Federal Register published notice 2010-4159, attributed to FDA and its parent HHS department, on 2010-03-01. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; FIRMAGON,” and PeptideScanner's exact reviewed identity mapping connects the document to Degarelix.","sourceIds":["federal-register-2010-4159-840a1c77b7d2"]},{"id":"paragraph-1","text":"The Federal Register published notice 2010-4159, attributed to FDA and its parent HHS department, on 2010-03-01. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; FIRMAGON,” and PeptideScanner's exact reviewed identity mapping connects the document to Degarelix.","sourceIds":["federal-register-2010-4159-840a1c77b7d2"]},{"id":"paragraph-2","text":"This page reports bounded metadata from a Federal Register document attributed to FDA and its parent HHS department, and links to the official GovInfo PDF. It does not interpret legal effect, approval, safety, effectiveness, compounding status, or medical use.","sourceIds":["federal-register-2010-4159-840a1c77b7d2"]}],"sources":[{"id":"federal-register-2010-4159-840a1c77b7d2","name":"Federal Register via GovInfo","sourceClass":"A","title":"Federal Register notice 2010-4159 · published 2010-03-01 · Determination of Regulatory Review Period for Purposes of Patent Extension; FIRMAGON","url":"https://www.govinfo.gov/content/pkg/FR-2010-03-01/pdf/2010-4159.pdf"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"50d7a5ec26f54ba2baa961fb75792763aa704b1b56a9d8f737b492af8166894c","tierARecordSha256":"840a1c77b7d2a61c64a0e038508c302739becf5242c424be5606231297aea6ae"},"integrity":{"algorithm":"sha256","contentSha256":"de1bf813ff0f7c773fc6bcddb7419e505983909a84dffc97ef0a442bb42fe928"}},"pubmed-pmid-19453267-degarelix-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-19453267-degarelix:v1","objectPathId":"pubmed-pmid-19453267-degarelix-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-19453267-degarelix/","json":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-19453267-degarelix-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#pubmed-pmid-19453267-degarelix-v1"},"story":{"slug":"pubmed-pmid-19453267-degarelix","version":1,"domain":"Literature metadata","dateInSource":"2009-05-26","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["degarelix"],"peptides":[{"slug":"degarelix","url":"https://peptidescanner.com/peptides/degarelix/"}]},"claims":[{"id":"headline","text":"Degarelix for prostate cancer.","sourceIds":["pubmed-observation-pmid-19453267-2009-05-26-fc6992720754"]},{"id":"summary","text":"PubMed lists PMID 19453267 in Expert opinion on investigational drugs as Journal Article, Review, with publication-date metadata of 2009-06 (month precision). PeptideScanner associated the retained record with the identity slug degarelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-19453267-2009-05-26-fc6992720754"]},{"id":"paragraph-1","text":"PubMed lists PMID 19453267 in Expert opinion on investigational drugs as Journal Article, Review, with publication-date metadata of 2009-06 (month precision). PeptideScanner associated the retained record with the identity slug degarelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-19453267-2009-05-26-fc6992720754"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-19453267-2009-05-26-fc6992720754"]}],"sources":[{"id":"pubmed-observation-pmid-19453267-2009-05-26-fc6992720754","name":"PubMed","sourceClass":"A","title":"Degarelix for prostate cancer. · retained source version 1:2009-05-26:current:fc6992720754d7b1ad06216cda6ee333a29a352455e65a31b01556dcc242f95b","url":"https://pubmed.ncbi.nlm.nih.gov/19453267/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"bd5b7c239ec2d8658ed208a866bf207375d58e229346d83f5202650f395936e0","tierARecordSha256":"e3870f61a51f01913ff39ba456c47d9a0f50c473380668288eeb6de4186de97d"},"integrity":{"algorithm":"sha256","contentSha256":"14d814b9ab79bbc56a661415ce1d36d0dbf7020664c7ff58ca93b0a8023eed9c"}},"pubmed-pmid-19838145-degarelix-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-19838145-degarelix:v1","objectPathId":"pubmed-pmid-19838145-degarelix-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-19838145-degarelix/","json":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-19838145-degarelix-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#pubmed-pmid-19838145-degarelix-v1"},"story":{"slug":"pubmed-pmid-19838145-degarelix","version":1,"domain":"Literature metadata","dateInSource":"2013-11-21","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["degarelix"],"peptides":[{"slug":"degarelix","url":"https://peptidescanner.com/peptides/degarelix/"}]},"claims":[{"id":"headline","text":"Degarelix (firmagon) for prostate cancer.","sourceIds":["pubmed-observation-pmid-19838145-2013-11-21-9ba14c348817"]},{"id":"summary","text":"PubMed lists PMID 19838145 in The Medical letter on drugs and therapeutics as Journal Article, Review, with publication-date metadata of 2009-10-19 (day precision). PeptideScanner associated the retained record with the identity slug degarelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-19838145-2013-11-21-9ba14c348817"]},{"id":"paragraph-1","text":"PubMed lists PMID 19838145 in The Medical letter on drugs and therapeutics as Journal Article, Review, with publication-date metadata of 2009-10-19 (day precision). PeptideScanner associated the retained record with the identity slug degarelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-19838145-2013-11-21-9ba14c348817"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-19838145-2013-11-21-9ba14c348817"]}],"sources":[{"id":"pubmed-observation-pmid-19838145-2013-11-21-9ba14c348817","name":"PubMed","sourceClass":"A","title":"Degarelix (firmagon) for prostate cancer. · retained source version 1:2013-11-21:current:9ba14c348817594200d71e532029469897af62c610731caeb2b488bd9f2a05c9","url":"https://pubmed.ncbi.nlm.nih.gov/19838145/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"964c2b1d4b97023c07506d6836604a4b0503311cbdcf85e0f103b653383cc9ec","tierARecordSha256":"e120338d9290f3e8ad21a53ad6cd6a3001beaaba8344934b15a43ba5c72ae39b"},"integrity":{"algorithm":"sha256","contentSha256":"abcb72e2966ae0e91551264d277ffd24bfd4148a15d3325cd538963eb6cfce99"}},"pubmed-pmid-20069136-degarelix-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-20069136-degarelix:v1","objectPathId":"pubmed-pmid-20069136-degarelix-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-20069136-degarelix/","json":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-20069136-degarelix-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#pubmed-pmid-20069136-degarelix-v1"},"story":{"slug":"pubmed-pmid-20069136-degarelix","version":1,"domain":"Literature metadata","dateInSource":"2025-08-04","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["degarelix"],"peptides":[{"slug":"degarelix","url":"https://peptidescanner.com/peptides/degarelix/"}]},"claims":[{"id":"headline","text":"Degarelix acetate for the treatment of prostate cancer.","sourceIds":["pubmed-observation-pmid-20069136-2025-08-04-8bd32370b4b9"]},{"id":"summary","text":"PubMed lists PMID 20069136 in Drugs of today (Barcelona, Spain : 1998) as Journal Article, Review, with publication-date metadata of 2009-10 (month precision). PeptideScanner associated the retained record with the identity slug degarelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-20069136-2025-08-04-8bd32370b4b9"]},{"id":"paragraph-1","text":"PubMed lists PMID 20069136 in Drugs of today (Barcelona, Spain : 1998) as Journal Article, Review, with publication-date metadata of 2009-10 (month precision). PeptideScanner associated the retained record with the identity slug degarelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-20069136-2025-08-04-8bd32370b4b9"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-20069136-2025-08-04-8bd32370b4b9"]}],"sources":[{"id":"pubmed-observation-pmid-20069136-2025-08-04-8bd32370b4b9","name":"PubMed","sourceClass":"A","title":"Degarelix acetate for the treatment of prostate cancer. · retained source version 1:2025-08-04:current:8bd32370b4b945b458937522e56818789a3c0cb3c278382a606aff8ee67ac039","url":"https://pubmed.ncbi.nlm.nih.gov/20069136/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"ca1931f1866d3e70930bdee0834dd0cfe4b3fb9612fd9148f6e7e91e23c01557","tierARecordSha256":"b3563a52b93e7960ed82c777c2c6619831710e5865174e2f110afe8180dcf41d"},"integrity":{"algorithm":"sha256","contentSha256":"9412422e7530d3bf6f8b7194ad6d295d7179a03ce0e30477ff22765925db069a"}},"pubmed-pmid-21188095-degarelix-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-21188095-degarelix:v1","objectPathId":"pubmed-pmid-21188095-degarelix-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-21188095-degarelix/","json":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-21188095-degarelix-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#pubmed-pmid-21188095-degarelix-v1"},"story":{"slug":"pubmed-pmid-21188095-degarelix","version":1,"domain":"Literature metadata","dateInSource":"2024-04-09","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["degarelix"],"peptides":[{"slug":"degarelix","url":"https://peptidescanner.com/peptides/degarelix/"}]},"claims":[{"id":"headline","text":"Evaluation of degarelix in the management of prostate cancer.","sourceIds":["pubmed-observation-pmid-21188095-2024-04-09-5a3bf71daf9a"]},{"id":"summary","text":"PubMed lists PMID 21188095 in Cancer management and research as Journal Article, with publication-date metadata of 2010-01-25 (day precision). PeptideScanner associated the retained record with the identity slug degarelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-21188095-2024-04-09-5a3bf71daf9a"]},{"id":"paragraph-1","text":"PubMed lists PMID 21188095 in Cancer management and research as Journal Article, with publication-date metadata of 2010-01-25 (day precision). PeptideScanner associated the retained record with the identity slug degarelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-21188095-2024-04-09-5a3bf71daf9a"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-21188095-2024-04-09-5a3bf71daf9a"]}],"sources":[{"id":"pubmed-observation-pmid-21188095-2024-04-09-5a3bf71daf9a","name":"PubMed","sourceClass":"A","title":"Evaluation of degarelix in the management of prostate cancer. · retained source version 1:2024-04-09:current:5a3bf71daf9aaefef898a6df23f418644d90dad1733f3dc8d6e70cfc5e438a0c","url":"https://pubmed.ncbi.nlm.nih.gov/21188095/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"30b81a0e937eaeb04b30d98ffac5df4e07d803012c929cd12e46b57952b89b14","tierARecordSha256":"e6c9750dfb173f7e266b2627959a5eca894f790dab412892efb3f7470709c49e"},"integrity":{"algorithm":"sha256","contentSha256":"71ffb27070d7b8061cafbd32ec38f81d28fc62ce617518fbd9887e3e544e6406"}},"pubmed-pmid-21496210-degarelix-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-21496210-degarelix:v1","objectPathId":"pubmed-pmid-21496210-degarelix-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-21496210-degarelix/","json":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-21496210-degarelix-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#pubmed-pmid-21496210-degarelix-v1"},"story":{"slug":"pubmed-pmid-21496210-degarelix","version":1,"domain":"Literature metadata","dateInSource":"2014-11-20","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["degarelix"],"peptides":[{"slug":"degarelix","url":"https://peptidescanner.com/peptides/degarelix/"}]},"claims":[{"id":"headline","text":"In vitro studies investigating the interactions between degarelix, a decapeptide gonadotropin-releasing hormone blocker, and cytochrome P450.","sourceIds":["pubmed-observation-pmid-21496210-2014-11-20-16a2f8e09d19"]},{"id":"summary","text":"PubMed lists PMID 21496210 in Basic & clinical pharmacology & toxicology as Journal Article, with publication-date metadata of 2011-05-23 (day precision). PeptideScanner associated the retained record with the identity slug degarelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-21496210-2014-11-20-16a2f8e09d19"]},{"id":"paragraph-1","text":"PubMed lists PMID 21496210 in Basic & clinical pharmacology & toxicology as Journal Article, with publication-date metadata of 2011-05-23 (day precision). PeptideScanner associated the retained record with the identity slug degarelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-21496210-2014-11-20-16a2f8e09d19"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-21496210-2014-11-20-16a2f8e09d19"]}],"sources":[{"id":"pubmed-observation-pmid-21496210-2014-11-20-16a2f8e09d19","name":"PubMed","sourceClass":"A","title":"In vitro studies investigating the interactions between degarelix, a decapeptide gonadotropin-releasing hormone blocker, and cytochrome P450. · retained source version 1:2014-11-20:current:16a2f8e09d19f99064417912fd2100a558bf5da31b6979bf8b7dc3f57391a138","url":"https://pubmed.ncbi.nlm.nih.gov/21496210/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"cd77aab5655dbfb606bc380bc5d53ead5c687bf8f2e5e249c32ffe9dce185091","tierARecordSha256":"bb97de67557037d7afd8bc78923d58ff63a071c416ca4ae7e519000d7f64eb81"},"integrity":{"algorithm":"sha256","contentSha256":"bd51c7c405a2606a3b112a1a2e01a18cf02e8627a83a236b30b44541547d116a"}},"pubmed-pmid-21768273-degarelix-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-21768273-degarelix:v1","objectPathId":"pubmed-pmid-21768273-degarelix-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-21768273-degarelix/","json":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-21768273-degarelix-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#pubmed-pmid-21768273-degarelix-v1"},"story":{"slug":"pubmed-pmid-21768273-degarelix","version":1,"domain":"Literature metadata","dateInSource":"2025-02-12","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["degarelix"],"peptides":[{"slug":"degarelix","url":"https://peptidescanner.com/peptides/degarelix/"}]},"claims":[{"id":"headline","text":"Metabolite profiles of degarelix, a new gonadotropin-releasing hormone receptor antagonist, in rat, dog, and monkey.","sourceIds":["pubmed-observation-pmid-21768273-2025-02-12-4344172fb21c"]},{"id":"summary","text":"PubMed lists PMID 21768273 in Drug metabolism and disposition: the biological fate of chemicals as Journal Article, with publication-date metadata of 2011-07-18 (day precision). PeptideScanner associated the retained record with the identity slug degarelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-21768273-2025-02-12-4344172fb21c"]},{"id":"paragraph-1","text":"PubMed lists PMID 21768273 in Drug metabolism and disposition: the biological fate of chemicals as Journal Article, with publication-date metadata of 2011-07-18 (day precision). PeptideScanner associated the retained record with the identity slug degarelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-21768273-2025-02-12-4344172fb21c"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-21768273-2025-02-12-4344172fb21c"]}],"sources":[{"id":"pubmed-observation-pmid-21768273-2025-02-12-4344172fb21c","name":"PubMed","sourceClass":"A","title":"Metabolite profiles of degarelix, a new gonadotropin-releasing hormone receptor antagonist, in rat, dog, and monkey. · retained source version 1:2025-02-12:current:4344172fb21ca80539cde28e2f249bb17476dccd58e6f8959cb49b4ba9234154","url":"https://pubmed.ncbi.nlm.nih.gov/21768273/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"65cbf472cb6c0416c174617a6d70bec1784427429ae33acbd1cfd6f2282ef05c","tierARecordSha256":"19ba6c3b136075d03c74ecda611cf57a886a9f2c7b7a6fb51bae88f800caa1ef"},"integrity":{"algorithm":"sha256","contentSha256":"da8446efbf1f20877c8b06ae280b1cf9ad70be9eeb763cd6769cb844afbd6c32"}},"pubmed-pmid-22082230-degarelix-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-22082230-degarelix:v1","objectPathId":"pubmed-pmid-22082230-degarelix-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-22082230-degarelix/","json":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-22082230-degarelix-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#pubmed-pmid-22082230-degarelix-v1"},"story":{"slug":"pubmed-pmid-22082230-degarelix","version":1,"domain":"Literature metadata","dateInSource":"2015-11-19","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["degarelix"],"peptides":[{"slug":"degarelix","url":"https://peptidescanner.com/peptides/degarelix/"}]},"claims":[{"id":"headline","text":"Degarelix: an antagonist to GnRH--theoretical and treatment considerations in paraphilia.","sourceIds":["pubmed-observation-pmid-22082230-2015-11-19-3b67ceb3a9c8"]},{"id":"summary","text":"PubMed lists PMID 22082230 in The journal of sexual medicine as Letter, with publication-date metadata of 2011-11-14 (day precision). PeptideScanner associated the retained record with the identity slug degarelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-22082230-2015-11-19-3b67ceb3a9c8"]},{"id":"paragraph-1","text":"PubMed lists PMID 22082230 in The journal of sexual medicine as Letter, with publication-date metadata of 2011-11-14 (day precision). PeptideScanner associated the retained record with the identity slug degarelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-22082230-2015-11-19-3b67ceb3a9c8"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-22082230-2015-11-19-3b67ceb3a9c8"]}],"sources":[{"id":"pubmed-observation-pmid-22082230-2015-11-19-3b67ceb3a9c8","name":"PubMed","sourceClass":"A","title":"Degarelix: an antagonist to GnRH--theoretical and treatment considerations in paraphilia. · retained source version 1:2015-11-19:current:3b67ceb3a9c8159f2ed03c8ac1b2fd92a460ba5b59147feeb09bb5aef035056a","url":"https://pubmed.ncbi.nlm.nih.gov/22082230/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"3a75ec6ae04c1513e65126cb9e713d0a166a28a3b426b4cc3c0bf44fa8f2127c","tierARecordSha256":"81a59716d6be30a2d496c536ed2b29ca6055963d9c561def7c83504de69b1144"},"integrity":{"algorithm":"sha256","contentSha256":"ad43e762afe07f55b3e74be61707bd2bd760dbde4ab13c3aec8ce756cf66379f"}},"pubmed-pmid-23431078-degarelix-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-23431078-degarelix:v1","objectPathId":"pubmed-pmid-23431078-degarelix-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-23431078-degarelix/","json":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-23431078-degarelix-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#pubmed-pmid-23431078-degarelix-v1"},"story":{"slug":"pubmed-pmid-23431078-degarelix","version":1,"domain":"Literature metadata","dateInSource":"2021-10-21","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["degarelix"],"peptides":[{"slug":"degarelix","url":"https://peptidescanner.com/peptides/degarelix/"}]},"claims":[{"id":"headline","text":"Degarelix as a new antiangiogenic agent for metastatic colon cancer?","sourceIds":["pubmed-observation-pmid-23431078-2021-10-21-4d353e334aa5"]},{"id":"summary","text":"PubMed lists PMID 23431078 in World journal of gastroenterology as Case Reports, Journal Article, with publication-date metadata of 2013-02-07 (day precision). PeptideScanner associated the retained record with the identity slug degarelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-23431078-2021-10-21-4d353e334aa5"]},{"id":"paragraph-1","text":"PubMed lists PMID 23431078 in World journal of gastroenterology as Case Reports, Journal Article, with publication-date metadata of 2013-02-07 (day precision). PeptideScanner associated the retained record with the identity slug degarelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-23431078-2021-10-21-4d353e334aa5"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-23431078-2021-10-21-4d353e334aa5"]}],"sources":[{"id":"pubmed-observation-pmid-23431078-2021-10-21-4d353e334aa5","name":"PubMed","sourceClass":"A","title":"Degarelix as a new antiangiogenic agent for metastatic colon cancer? · retained source version 1:2021-10-21:current:4d353e334aa568d579a4509a6a06a1928541665f9059806b63ef0ff2ed603b68","url":"https://pubmed.ncbi.nlm.nih.gov/23431078/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"5c0aa27e828ace83f91ba6b525d88c2e2b5d632b2e008e6e9204bf65a4a4e512","tierARecordSha256":"818ac620fb910b9dd1d524ef7eeb6e5a3c1b09b91b61e513134a56a08492395e"},"integrity":{"algorithm":"sha256","contentSha256":"9b23713036a883f481ff5cade20f64d024794b8f403896b9719fa22d9f01b0ac"}},"pubmed-pmid-23589543-degarelix-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-23589543-degarelix:v1","objectPathId":"pubmed-pmid-23589543-degarelix-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-23589543-degarelix/","json":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-23589543-degarelix-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#pubmed-pmid-23589543-degarelix-v1"},"story":{"slug":"pubmed-pmid-23589543-degarelix","version":1,"domain":"Literature metadata","dateInSource":"2025-02-12","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["degarelix"],"peptides":[{"slug":"degarelix","url":"https://peptidescanner.com/peptides/degarelix/"}]},"claims":[{"id":"headline","text":"In vitro and in vivo human metabolism of degarelix, a gonadotropin-releasing hormone receptor blocker.","sourceIds":["pubmed-observation-pmid-23589543-2025-02-12-493aea957144"]},{"id":"summary","text":"PubMed lists PMID 23589543 in Drug metabolism and disposition: the biological fate of chemicals as Journal Article, with publication-date metadata of 2013-04-15 (day precision). PeptideScanner associated the retained record with the identity slug degarelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-23589543-2025-02-12-493aea957144"]},{"id":"paragraph-1","text":"PubMed lists PMID 23589543 in Drug metabolism and disposition: the biological fate of chemicals as Journal Article, with publication-date metadata of 2013-04-15 (day precision). PeptideScanner associated the retained record with the identity slug degarelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-23589543-2025-02-12-493aea957144"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-23589543-2025-02-12-493aea957144"]}],"sources":[{"id":"pubmed-observation-pmid-23589543-2025-02-12-493aea957144","name":"PubMed","sourceClass":"A","title":"In vitro and in vivo human metabolism of degarelix, a gonadotropin-releasing hormone receptor blocker. · retained source version 1:2025-02-12:current:493aea957144003f58abc05f836ab02dcee3e0619028ceb66b3df23ea1465eef","url":"https://pubmed.ncbi.nlm.nih.gov/23589543/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"82147d9f81cf1a6bd021602f4a85734dde735a0f1d7b9ecf0981b3e21aacb767","tierARecordSha256":"34db79ca508b7609c139181322be17c21b6789aee2578bbf75292d521a002ee4"},"integrity":{"algorithm":"sha256","contentSha256":"a871580e8dbf6b72c0f19c386121424ee379e9aa24771129ab702d50dfb1623a"}},"pubmed-pmid-23783053-degarelix-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-23783053-degarelix:v1","objectPathId":"pubmed-pmid-23783053-degarelix-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-23783053-degarelix/","json":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-23783053-degarelix-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#pubmed-pmid-23783053-degarelix-v1"},"story":{"slug":"pubmed-pmid-23783053-degarelix","version":1,"domain":"Literature metadata","dateInSource":"2013-06-20","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["degarelix"],"peptides":[{"slug":"degarelix","url":"https://peptidescanner.com/peptides/degarelix/"}]},"claims":[{"id":"headline","text":"Management of a patient with locally advanced prostate cancer with degarelix: a case report.","sourceIds":["pubmed-observation-pmid-23783053-2013-06-20-0e1c63287072"]},{"id":"summary","text":"PubMed lists PMID 23783053 in The Canadian journal of urology as Case Reports, Journal Article, with publication-date metadata of 2013-06 (month precision). PeptideScanner associated the retained record with the identity slug degarelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-23783053-2013-06-20-0e1c63287072"]},{"id":"paragraph-1","text":"PubMed lists PMID 23783053 in The Canadian journal of urology as Case Reports, Journal Article, with publication-date metadata of 2013-06 (month precision). PeptideScanner associated the retained record with the identity slug degarelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-23783053-2013-06-20-0e1c63287072"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-23783053-2013-06-20-0e1c63287072"]}],"sources":[{"id":"pubmed-observation-pmid-23783053-2013-06-20-0e1c63287072","name":"PubMed","sourceClass":"A","title":"Management of a patient with locally advanced prostate cancer with degarelix: a case report. · retained source version 1:2013-06-20:current:0e1c6328707218feaa7278ed451be100804209d47e8d886a9e95aa9c4b51f54b","url":"https://pubmed.ncbi.nlm.nih.gov/23783053/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"08e7a8fd1536fb3fa3399d9021659694b8b1a00d65db260e174974dcb5678721","tierARecordSha256":"71a959e8f195a206ce1232576b2ace24862649d02827eff40055fcecc8dcd92b"},"integrity":{"algorithm":"sha256","contentSha256":"ef2710f128d4f5e6c84508d5fc61051d21bef1a8f192bc966a8274596d40f599"}},"pubmed-pmid-24473414-degarelix-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-24473414-degarelix:v1","objectPathId":"pubmed-pmid-24473414-degarelix-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-24473414-degarelix/","json":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-24473414-degarelix-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#pubmed-pmid-24473414-degarelix-v1"},"story":{"slug":"pubmed-pmid-24473414-degarelix","version":1,"domain":"Literature metadata","dateInSource":"2021-10-21","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["degarelix"],"peptides":[{"slug":"degarelix","url":"https://peptidescanner.com/peptides/degarelix/"}]},"claims":[{"id":"headline","text":"Tipping the balance in favour of degarelix for ADT.","sourceIds":["pubmed-observation-pmid-24473414-2021-10-21-43be7bd4ccae"]},{"id":"summary","text":"PubMed lists PMID 24473414 in Nature reviews. Urology as Journal Article, with publication-date metadata of 2014-01-28 (day precision). PeptideScanner associated the retained record with the identity slug degarelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-24473414-2021-10-21-43be7bd4ccae"]},{"id":"paragraph-1","text":"PubMed lists PMID 24473414 in Nature reviews. Urology as Journal Article, with publication-date metadata of 2014-01-28 (day precision). PeptideScanner associated the retained record with the identity slug degarelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-24473414-2021-10-21-43be7bd4ccae"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-24473414-2021-10-21-43be7bd4ccae"]}],"sources":[{"id":"pubmed-observation-pmid-24473414-2021-10-21-43be7bd4ccae","name":"PubMed","sourceClass":"A","title":"Tipping the balance in favour of degarelix for ADT. · retained source version 1:2021-10-21:current:43be7bd4ccae6a45e40c29a9f5bb6981d8295988e07b9b95b267556160230fe0","url":"https://pubmed.ncbi.nlm.nih.gov/24473414/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"6fe311d741beef1f203391bc1b5c21f293b729e79c2940c3205d5e87641a808d","tierARecordSha256":"62cdf80d32731cd38f65a5705a46fc0f86bc862162bea9b224f3b5b35f1c2c4e"},"integrity":{"algorithm":"sha256","contentSha256":"43f29eb0032a49fe0b461b27d778ff7f41732e9f77a1d10185b41cb6c8fdb212"}},"pubmed-pmid-24568188-degarelix-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-24568188-degarelix:v1","objectPathId":"pubmed-pmid-24568188-degarelix-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-24568188-degarelix/","json":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-24568188-degarelix-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#pubmed-pmid-24568188-degarelix-v1"},"story":{"slug":"pubmed-pmid-24568188-degarelix","version":1,"domain":"Literature metadata","dateInSource":"2026-01-28","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["degarelix"],"peptides":[{"slug":"degarelix","url":"https://peptidescanner.com/peptides/degarelix/"}]},"claims":[{"id":"headline","text":"A cost-utility analysis of degarelix in the treatment of advanced hormone-dependent prostate cancer in the United Kingdom.","sourceIds":["pubmed-observation-pmid-24568188-2026-01-28-8c5cab4b2691"]},{"id":"summary","text":"PubMed lists PMID 24568188 in Journal of medical economics as Comparative Study, Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2014-02-25 (day precision). PeptideScanner associated the retained record with the identity slug degarelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-24568188-2026-01-28-8c5cab4b2691"]},{"id":"paragraph-1","text":"PubMed lists PMID 24568188 in Journal of medical economics as Comparative Study, Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2014-02-25 (day precision). PeptideScanner associated the retained record with the identity slug degarelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-24568188-2026-01-28-8c5cab4b2691"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-24568188-2026-01-28-8c5cab4b2691"]}],"sources":[{"id":"pubmed-observation-pmid-24568188-2026-01-28-8c5cab4b2691","name":"PubMed","sourceClass":"A","title":"A cost-utility analysis of degarelix in the treatment of advanced hormone-dependent prostate cancer in the United Kingdom. · retained source version 1:2026-01-28:current:8c5cab4b2691a5c47ec21e60b95cbc68e41a9642c930939625b7a163186d5758","url":"https://pubmed.ncbi.nlm.nih.gov/24568188/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"88be1bbc581c0cf0cb9ac65e0ac5563a09860245a94e9406ce762f00c1d8c7fc","tierARecordSha256":"bbd5f5c75d17e56f8db53019c13aced966a1e0d89b203bf7217bbe120f749d3d"},"integrity":{"algorithm":"sha256","contentSha256":"d00478db81ed88a02d5b4b24fd8877dfc8cc7244893eabc394ce328ab4c23a20"}},"pubmed-pmid-25851250-degarelix-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-25851250-degarelix:v1","objectPathId":"pubmed-pmid-25851250-degarelix-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-25851250-degarelix/","json":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-25851250-degarelix-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#pubmed-pmid-25851250-degarelix-v1"},"story":{"slug":"pubmed-pmid-25851250-degarelix","version":1,"domain":"Literature metadata","dateInSource":"2015-06-23","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["degarelix"],"peptides":[{"slug":"degarelix","url":"https://peptidescanner.com/peptides/degarelix/"}]},"claims":[{"id":"headline","text":"Gonadotropin-releasing hormone receptor-targeted paclitaxel-degarelix conjugate: synthesis and in vitro evaluation.","sourceIds":["pubmed-observation-pmid-25851250-2015-06-23-03ee99941d89"]},{"id":"summary","text":"PubMed lists PMID 25851250 in Journal of peptide science : an official publication of the European Peptide Society as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2015-04-08 (day precision). PeptideScanner associated the retained record with the identity slug degarelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-25851250-2015-06-23-03ee99941d89"]},{"id":"paragraph-1","text":"PubMed lists PMID 25851250 in Journal of peptide science : an official publication of the European Peptide Society as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2015-04-08 (day precision). PeptideScanner associated the retained record with the identity slug degarelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-25851250-2015-06-23-03ee99941d89"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-25851250-2015-06-23-03ee99941d89"]}],"sources":[{"id":"pubmed-observation-pmid-25851250-2015-06-23-03ee99941d89","name":"PubMed","sourceClass":"A","title":"Gonadotropin-releasing hormone receptor-targeted paclitaxel-degarelix conjugate: synthesis and in vitro evaluation. · retained source version 1:2015-06-23:current:03ee99941d89cf1a6e157bf3932b3bbc1120ae0c3c7c1f90754eb1b98806aabe","url":"https://pubmed.ncbi.nlm.nih.gov/25851250/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"56e0c157a43ba10f570b334472d923c643ff85982a9465af38baffe894ad5b77","tierARecordSha256":"1a4f9eb0ed019740130db6bea577e292637a5fb9dbfda938733646c8992dd53d"},"integrity":{"algorithm":"sha256","contentSha256":"2cb3a6379f6fe4e1d5c3c0538b03a3e36bb67d9d819b575368e5bb5a41f43ecb"}},"pubmed-pmid-27756786-degarelix-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-27756786-degarelix:v1","objectPathId":"pubmed-pmid-27756786-degarelix-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-27756786-degarelix/","json":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-27756786-degarelix-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#pubmed-pmid-27756786-degarelix-v1"},"story":{"slug":"pubmed-pmid-27756786-degarelix","version":1,"domain":"Literature metadata","dateInSource":"2017-11-07","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["degarelix"],"peptides":[{"slug":"degarelix","url":"https://peptidescanner.com/peptides/degarelix/"}]},"claims":[{"id":"headline","text":"A Phase II, Randomized, Open-Label Study of Neoadjuvant Degarelix versus LHRH Agonist in Prostate Cancer Patients Prior to Radical Prostatectomy.","sourceIds":["pubmed-observation-pmid-27756786-2017-11-07-ec7c8bc0749b"]},{"id":"summary","text":"PubMed lists PMID 27756786 in Clinical cancer research : an official journal of the American Association for Cancer Research as Clinical Trial, Phase II, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2016-10-18 (day precision). PeptideScanner associated the retained record with the identity slug degarelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-27756786-2017-11-07-ec7c8bc0749b"]},{"id":"paragraph-1","text":"PubMed lists PMID 27756786 in Clinical cancer research : an official journal of the American Association for Cancer Research as Clinical Trial, Phase II, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2016-10-18 (day precision). PeptideScanner associated the retained record with the identity slug degarelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-27756786-2017-11-07-ec7c8bc0749b"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-27756786-2017-11-07-ec7c8bc0749b"]}],"sources":[{"id":"pubmed-observation-pmid-27756786-2017-11-07-ec7c8bc0749b","name":"PubMed","sourceClass":"A","title":"A Phase II, Randomized, Open-Label Study of Neoadjuvant Degarelix versus LHRH Agonist in Prostate Cancer Patients Prior to Radical Prostatectomy. · retained source version 1:2017-11-07:current:ec7c8bc0749b153600ec6b8b788599df0b8cafd3f344daca2379daa9d3267af0","url":"https://pubmed.ncbi.nlm.nih.gov/27756786/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"9efa8c0ae4f2401ad106ed1d5655d9d5309be0b7bcdc2b5c546ed00a5b14e220","tierARecordSha256":"0749b66b54320df1e732005ed8627b2bb184d52c1579547e8356d08d9ae7144d"},"integrity":{"algorithm":"sha256","contentSha256":"070acaeaf167f6ead61df4ee77b030ed263654b2b97b2937b8609155daa4b760"}},"pubmed-pmid-28480768-degarelix-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-28480768-degarelix:v1","objectPathId":"pubmed-pmid-28480768-degarelix-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-28480768-degarelix/","json":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-28480768-degarelix-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#pubmed-pmid-28480768-degarelix-v1"},"story":{"slug":"pubmed-pmid-28480768-degarelix","version":1,"domain":"Literature metadata","dateInSource":"2024-07-28","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["degarelix"],"peptides":[{"slug":"degarelix","url":"https://peptidescanner.com/peptides/degarelix/"}]},"claims":[{"id":"headline","text":"Degarelix versus luteinizing hormone-releasing hormone agonists for the treatment of prostate cancer.","sourceIds":["pubmed-observation-pmid-28480768-2024-07-28-03b111893bbf"]},{"id":"summary","text":"PubMed lists PMID 28480768 in Expert opinion on pharmacotherapy as Journal Article, Review, with publication-date metadata of 2017-05-19 (day precision). PeptideScanner associated the retained record with the identity slug degarelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-28480768-2024-07-28-03b111893bbf"]},{"id":"paragraph-1","text":"PubMed lists PMID 28480768 in Expert opinion on pharmacotherapy as Journal Article, Review, with publication-date metadata of 2017-05-19 (day precision). PeptideScanner associated the retained record with the identity slug degarelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-28480768-2024-07-28-03b111893bbf"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-28480768-2024-07-28-03b111893bbf"]}],"sources":[{"id":"pubmed-observation-pmid-28480768-2024-07-28-03b111893bbf","name":"PubMed","sourceClass":"A","title":"Degarelix versus luteinizing hormone-releasing hormone agonists for the treatment of prostate cancer. · retained source version 1:2024-07-28:current:03b111893bbfdfb169b31af4fb6cedbf34152a667f091416b91168dcd9470058","url":"https://pubmed.ncbi.nlm.nih.gov/28480768/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"8b9523a8287818884901933f84a86013715346f75fb244d6df234788c14ba097","tierARecordSha256":"4605087c75d518bcd7427d7584fbd5cd86fe13e422d0a8cdc1664919f38fec11"},"integrity":{"algorithm":"sha256","contentSha256":"1a54ed617b3c40b7896ec7423a89b0b2a6875f4dfea685e3d7ef35fa36bfc156"}},"pubmed-pmid-28753747-degarelix-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-28753747-degarelix:v1","objectPathId":"pubmed-pmid-28753747-degarelix-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-28753747-degarelix/","json":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-28753747-degarelix-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#pubmed-pmid-28753747-degarelix-v1"},"story":{"slug":"pubmed-pmid-28753747-degarelix","version":1,"domain":"Literature metadata","dateInSource":"2018-12-17","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["degarelix"],"peptides":[{"slug":"degarelix","url":"https://peptidescanner.com/peptides/degarelix/"}]},"claims":[{"id":"headline","text":"Factors Predicting the Off-treatment Duration in Patients with Prostate Cancer Receiving Degarelix as Intermittent Androgen Deprivation Therapy.","sourceIds":["pubmed-observation-pmid-28753747-2018-12-17-71c036f770a7"]},{"id":"summary","text":"PubMed lists PMID 28753747 in European urology focus as Clinical Trial, Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't, with publication-date metadata of 2016-01-22 (day precision). PeptideScanner associated the retained record with the identity slug degarelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-28753747-2018-12-17-71c036f770a7"]},{"id":"paragraph-1","text":"PubMed lists PMID 28753747 in European urology focus as Clinical Trial, Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't, with publication-date metadata of 2016-01-22 (day precision). PeptideScanner associated the retained record with the identity slug degarelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-28753747-2018-12-17-71c036f770a7"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-28753747-2018-12-17-71c036f770a7"]}],"sources":[{"id":"pubmed-observation-pmid-28753747-2018-12-17-71c036f770a7","name":"PubMed","sourceClass":"A","title":"Factors Predicting the Off-treatment Duration in Patients with Prostate Cancer Receiving Degarelix as Intermittent Androgen Deprivation Therapy. · retained source version 1:2018-12-17:current:71c036f770a738a815dc289288707cfb745bf0fcdd983e9dcc63adde7a667629","url":"https://pubmed.ncbi.nlm.nih.gov/28753747/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"8f58012cd3f53befbf508a66dadad59d70d89e9fb2c42efe4167cdd3d2c6579c","tierARecordSha256":"cdaba191d1fe607512a0752b1373933e048e9abb4e0f5491d80f4d39b474884b"},"integrity":{"algorithm":"sha256","contentSha256":"b6aee97304d142281a65e095cfa0ba21df13e8ecc06f2065c5b3f5ab170110b8"}},"pubmed-pmid-28960413-degarelix-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-28960413-degarelix:v1","objectPathId":"pubmed-pmid-28960413-degarelix-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-28960413-degarelix/","json":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-28960413-degarelix-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#pubmed-pmid-28960413-degarelix-v1"},"story":{"slug":"pubmed-pmid-28960413-degarelix","version":1,"domain":"Literature metadata","dateInSource":"2019-09-11","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["degarelix"],"peptides":[{"slug":"degarelix","url":"https://peptidescanner.com/peptides/degarelix/"}]},"claims":[{"id":"headline","text":"An efficient synthesis of deuterium-labeled degarelix acetate, a third-generation gonadotropin-releasing hormone receptor antagonist.","sourceIds":["pubmed-observation-pmid-28960413-2019-09-11-33dbc001e266"]},{"id":"summary","text":"PubMed lists PMID 28960413 in Journal of labelled compounds & radiopharmaceuticals as Journal Article, with publication-date metadata of 2018-03-15 (day precision). PeptideScanner associated the retained record with the identity slug degarelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-28960413-2019-09-11-33dbc001e266"]},{"id":"paragraph-1","text":"PubMed lists PMID 28960413 in Journal of labelled compounds & radiopharmaceuticals as Journal Article, with publication-date metadata of 2018-03-15 (day precision). PeptideScanner associated the retained record with the identity slug degarelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-28960413-2019-09-11-33dbc001e266"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-28960413-2019-09-11-33dbc001e266"]}],"sources":[{"id":"pubmed-observation-pmid-28960413-2019-09-11-33dbc001e266","name":"PubMed","sourceClass":"A","title":"An efficient synthesis of deuterium-labeled degarelix acetate, a third-generation gonadotropin-releasing hormone receptor antagonist. · retained source version 1:2019-09-11:current:33dbc001e26613f129d2b43e4a09538655d234d624c5b35f143e754dc50968cd","url":"https://pubmed.ncbi.nlm.nih.gov/28960413/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"591b4cf85d38b8ffce683e00d07a68e4e22fd4dbfd11bdeeb5d5740aef3d75ff","tierARecordSha256":"fc30ef0922d8fbff0fae8d36d555d241f7f7e47d4474b657e19b65e16a6f90b8"},"integrity":{"algorithm":"sha256","contentSha256":"5fd610f5563210469680b8e7cf3f21967e380e1f9a816db34099c6aff2753d20"}},"pubmed-pmid-29264358-degarelix-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-29264358-degarelix:v1","objectPathId":"pubmed-pmid-29264358-degarelix-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-29264358-degarelix/","json":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-29264358-degarelix-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#pubmed-pmid-29264358-degarelix-v1"},"story":{"slug":"pubmed-pmid-29264358-degarelix","version":1,"domain":"Literature metadata","dateInSource":"2022-03-11","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["degarelix"],"peptides":[{"slug":"degarelix","url":"https://peptidescanner.com/peptides/degarelix/"}]},"claims":[{"id":"headline","text":"Degarelix treatment is compatible with diabetes and antithrombotic therapy in patients with prostate cancer.","sourceIds":["pubmed-observation-pmid-29264358-2022-03-11-a7ae0cbb1597"]},{"id":"summary","text":"PubMed lists PMID 29264358 in Research and reports in urology as Journal Article, with publication-date metadata of 2017-12-06 (day precision). PeptideScanner associated the retained record with the identity slug degarelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-29264358-2022-03-11-a7ae0cbb1597"]},{"id":"paragraph-1","text":"PubMed lists PMID 29264358 in Research and reports in urology as Journal Article, with publication-date metadata of 2017-12-06 (day precision). PeptideScanner associated the retained record with the identity slug degarelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-29264358-2022-03-11-a7ae0cbb1597"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-29264358-2022-03-11-a7ae0cbb1597"]}],"sources":[{"id":"pubmed-observation-pmid-29264358-2022-03-11-a7ae0cbb1597","name":"PubMed","sourceClass":"A","title":"Degarelix treatment is compatible with diabetes and antithrombotic therapy in patients with prostate cancer. · retained source version 1:2022-03-11:current:a7ae0cbb1597911380a1c9fac67ec8282051896fc2e25495b87ba6b232a49151","url":"https://pubmed.ncbi.nlm.nih.gov/29264358/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"287108f814d79206ab51ffde363066c6037cbc5c418b1375e64c012021eb69a2","tierARecordSha256":"ebb0c0fb61f19577264e2eb7dd37fac84d162dce2a68539226fd4a36603976c2"},"integrity":{"algorithm":"sha256","contentSha256":"30b182735c41002d2bd54a25db2fc9ef0afd3160094f3a6b1e120de10be407b0"}},"pubmed-pmid-29534997-degarelix-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-29534997-degarelix:v1","objectPathId":"pubmed-pmid-29534997-degarelix-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-29534997-degarelix/","json":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-29534997-degarelix-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#pubmed-pmid-29534997-degarelix-v1"},"story":{"slug":"pubmed-pmid-29534997-degarelix","version":1,"domain":"Literature metadata","dateInSource":"2021-11-22","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["degarelix"],"peptides":[{"slug":"degarelix","url":"https://peptidescanner.com/peptides/degarelix/"}]},"claims":[{"id":"headline","text":"A Phase II, Randomized, Multicenter Study Comparing 10 Months versus 4 Months of Degarelix Therapy in Prolonging the Off Treatment Interval in Men with Localized Prostate Cancer Receiving Intermitten…","sourceIds":["pubmed-observation-pmid-29534997-2021-11-22-4f2338798225"]},{"id":"summary","text":"PubMed lists PMID 29534997 in The Journal of urology as Clinical Trial, Phase II, Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial, with publication-date metadata of 2018-03-11 (day precision). PeptideScanner associated the retained record with the identity slug degarelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-29534997-2021-11-22-4f2338798225"]},{"id":"paragraph-1","text":"PubMed lists PMID 29534997 in The Journal of urology as Clinical Trial, Phase II, Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial, with publication-date metadata of 2018-03-11 (day precision). PeptideScanner associated the retained record with the identity slug degarelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-29534997-2021-11-22-4f2338798225"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-29534997-2021-11-22-4f2338798225"]}],"sources":[{"id":"pubmed-observation-pmid-29534997-2021-11-22-4f2338798225","name":"PubMed","sourceClass":"A","title":"A Phase II, Randomized, Multicenter Study Comparing 10 Months versus 4 Months of Degarelix Therapy in Prolonging the Off Treatment Interval in Men with Localized Prostate Cancer Receiving Intermittent Androgen Deprivation Therapy for Biochemical Recurrence following Radical Local Therapy. · retained source version 1:2021-11-22:current:4f2338798225b412464c6840977c321bd9720d8df6dae0432e6bef9b85b402e6","url":"https://pubmed.ncbi.nlm.nih.gov/29534997/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"f645c4d1fa067f3b8d3d713144903608af685570da240c9371d93555d259776b","tierARecordSha256":"ea860df000168baf6877244e4288afa86fccd977bb5da5a33659fb49b9927f79"},"integrity":{"algorithm":"sha256","contentSha256":"708cd6d3b026dc042f4c64bd7f7a326e1ae62a58f246a7883668b25564189def"}},"pubmed-pmid-32573666-degarelix-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-32573666-degarelix:v1","objectPathId":"pubmed-pmid-32573666-degarelix-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-32573666-degarelix/","json":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-32573666-degarelix-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#pubmed-pmid-32573666-degarelix-v1"},"story":{"slug":"pubmed-pmid-32573666-degarelix","version":1,"domain":"Literature metadata","dateInSource":"2020-06-26","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["degarelix"],"peptides":[{"slug":"degarelix","url":"https://peptidescanner.com/peptides/degarelix/"}]},"claims":[{"id":"headline","text":"Prostate Cancer Drug Degarelix Rapidly Treats Pedophilic Disorder.","sourceIds":["pubmed-observation-pmid-32573666-2020-06-26-9a310767e82a"]},{"id":"summary","text":"PubMed lists PMID 32573666 in JAMA as Journal Article, with publication-date metadata of 2020-06-23 (day precision). PeptideScanner associated the retained record with the identity slug degarelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-32573666-2020-06-26-9a310767e82a"]},{"id":"paragraph-1","text":"PubMed lists PMID 32573666 in JAMA as Journal Article, with publication-date metadata of 2020-06-23 (day precision). PeptideScanner associated the retained record with the identity slug degarelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-32573666-2020-06-26-9a310767e82a"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-32573666-2020-06-26-9a310767e82a"]}],"sources":[{"id":"pubmed-observation-pmid-32573666-2020-06-26-9a310767e82a","name":"PubMed","sourceClass":"A","title":"Prostate Cancer Drug Degarelix Rapidly Treats Pedophilic Disorder. · retained source version 1:2020-06-26:current:9a310767e82a36537279a2bb4f116d7fe0dbe73d107ffce87069af843db4b07f","url":"https://pubmed.ncbi.nlm.nih.gov/32573666/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"cd7569332b44a341b2ce655d2d4924b2d483476a718cf06a392f4f9e63980601","tierARecordSha256":"c2b02ebe89f135693338c8b8fafe69fad8458f70a466c70e0c3ef5ef4c117d61"},"integrity":{"algorithm":"sha256","contentSha256":"3ad95889db836c1906bbf128aaf2f816aff0286ec7ce9900a5afef1d9e738f6c"}},"pubmed-pmid-33586081-degarelix-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-33586081-degarelix:v1","objectPathId":"pubmed-pmid-33586081-degarelix-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-33586081-degarelix/","json":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-33586081-degarelix-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#pubmed-pmid-33586081-degarelix-v1"},"story":{"slug":"pubmed-pmid-33586081-degarelix","version":1,"domain":"Literature metadata","dateInSource":"2021-03-24","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["degarelix"],"peptides":[{"slug":"degarelix","url":"https://peptidescanner.com/peptides/degarelix/"}]},"claims":[{"id":"headline","text":"A Real-Time NMR Method for Measurement of In Vitro Aggregation Kinetics Of Degarelix Drug Products.","sourceIds":["pubmed-observation-pmid-33586081-2021-03-24-bee13d21ce29"]},{"id":"summary","text":"PubMed lists PMID 33586081 in AAPS PharmSciTech as Journal Article, with publication-date metadata of 2021-02-14 (day precision). PeptideScanner associated the retained record with the identity slug degarelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-33586081-2021-03-24-bee13d21ce29"]},{"id":"paragraph-1","text":"PubMed lists PMID 33586081 in AAPS PharmSciTech as Journal Article, with publication-date metadata of 2021-02-14 (day precision). PeptideScanner associated the retained record with the identity slug degarelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-33586081-2021-03-24-bee13d21ce29"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-33586081-2021-03-24-bee13d21ce29"]}],"sources":[{"id":"pubmed-observation-pmid-33586081-2021-03-24-bee13d21ce29","name":"PubMed","sourceClass":"A","title":"A Real-Time NMR Method for Measurement of In Vitro Aggregation Kinetics Of Degarelix Drug Products. · retained source version 1:2021-03-24:current:bee13d21ce2949840ad27b43b7bc1a3d3f926ff4f0fa95bc21966f6e465d6d23","url":"https://pubmed.ncbi.nlm.nih.gov/33586081/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"4b5e3ee929855c8c6cb6ed0ed6920002faf7ab7f0543628e62bd99687556f740","tierARecordSha256":"e0d900db84db5a02f47676859a7c55d287631c69bf68383d131a5ba67ec0dced"},"integrity":{"algorithm":"sha256","contentSha256":"795994ffa4459d44c8e11e49a164928dff4f63eed6a11d99e281daf923a18fe8"}},"pubmed-pmid-34350976-degarelix-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-34350976-degarelix:v1","objectPathId":"pubmed-pmid-34350976-degarelix-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-34350976-degarelix/","json":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-34350976-degarelix-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#pubmed-pmid-34350976-degarelix-v1"},"story":{"slug":"pubmed-pmid-34350976-degarelix","version":1,"domain":"Literature metadata","dateInSource":"2025-06-23","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["degarelix"],"peptides":[{"slug":"degarelix","url":"https://peptidescanner.com/peptides/degarelix/"}]},"claims":[{"id":"headline","text":"Degarelix for treating advanced hormone-sensitive prostate cancer.","sourceIds":["pubmed-observation-pmid-34350976-2025-06-23-15b6f0395855"]},{"id":"summary","text":"PubMed lists PMID 34350976 in The Cochrane database of systematic reviews as Journal Article, Research Support, Non-U.S. Gov't, Systematic Review, with publication-date metadata of 2021-08-05 (day precision). PeptideScanner associated the retained record with the identity slug degarelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-34350976-2025-06-23-15b6f0395855"]},{"id":"paragraph-1","text":"PubMed lists PMID 34350976 in The Cochrane database of systematic reviews as Journal Article, Research Support, Non-U.S. Gov't, Systematic Review, with publication-date metadata of 2021-08-05 (day precision). PeptideScanner associated the retained record with the identity slug degarelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-34350976-2025-06-23-15b6f0395855"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-34350976-2025-06-23-15b6f0395855"]}],"sources":[{"id":"pubmed-observation-pmid-34350976-2025-06-23-15b6f0395855","name":"PubMed","sourceClass":"A","title":"Degarelix for treating advanced hormone-sensitive prostate cancer. · retained source version 1:2025-06-23:current:15b6f0395855faeb060496b7d3b5ad12053d8b433be4d58a3f412f5cbeff574a","url":"https://pubmed.ncbi.nlm.nih.gov/34350976/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"aadd24f4bfaa5b33bf33de48810e724739d8d9b514ff0ec367bea3b288c8ec8c","tierARecordSha256":"47386d7e853f3576e6ed7b6f11fae7a00378a42b59466bc90725fc200d83064c"},"integrity":{"algorithm":"sha256","contentSha256":"66b3ce348c82c45aa22f3c1c4ef8868d9d0650238e56bb1b25d302e1d1854d52"}},"pubmed-pmid-34907463-degarelix-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-34907463-degarelix:v1","objectPathId":"pubmed-pmid-34907463-degarelix-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-34907463-degarelix/","json":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-34907463-degarelix-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#pubmed-pmid-34907463-degarelix-v1"},"story":{"slug":"pubmed-pmid-34907463-degarelix","version":1,"domain":"Literature metadata","dateInSource":"2026-10-10","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["degarelix"],"peptides":[{"slug":"degarelix","url":"https://peptidescanner.com/peptides/degarelix/"}]},"claims":[{"id":"headline","text":"[Treatment of advanced hormone-sensitive prostate cancer using degarelix].","sourceIds":["pubmed-observation-pmid-34907463-2026-10-10-14af73972c53"]},{"id":"summary","text":"PubMed lists PMID 34907463 in Der Urologe. Ausg. A as Journal Article, Review, with publication-date metadata of 2021-12-14 (day precision). PeptideScanner associated the retained record with the identity slug degarelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-34907463-2026-10-10-14af73972c53"]},{"id":"paragraph-1","text":"PubMed lists PMID 34907463 in Der Urologe. Ausg. A as Journal Article, Review, with publication-date metadata of 2021-12-14 (day precision). PeptideScanner associated the retained record with the identity slug degarelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-34907463-2026-10-10-14af73972c53"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-34907463-2026-10-10-14af73972c53"]}],"sources":[{"id":"pubmed-observation-pmid-34907463-2026-10-10-14af73972c53","name":"PubMed","sourceClass":"A","title":"[Treatment of advanced hormone-sensitive prostate cancer using degarelix]. · retained source version 1:2026-10-10:current:14af73972c5315659d7c955dd62cd4772720eee862f122d9042d7fbb2ad6a88f","url":"https://pubmed.ncbi.nlm.nih.gov/34907463/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"8cd09146b2ecb8f9f831c2007a7f4f8b96a36c851ebf24a471f78d4677fff2ed","tierARecordSha256":"6256d805e5611ccd4e684c34995001b46cb42438e9b2b336139c207a692c983b"},"integrity":{"algorithm":"sha256","contentSha256":"12317cb77a3301913b1903a591143e6380db9a607a10eed3c862abbf947eb848"}},"pubmed-pmid-34934969-degarelix-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-34934969-degarelix:v1","objectPathId":"pubmed-pmid-34934969-degarelix-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-34934969-degarelix/","json":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-34934969-degarelix-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#pubmed-pmid-34934969-degarelix-v1"},"story":{"slug":"pubmed-pmid-34934969-degarelix","version":1,"domain":"Literature metadata","dateInSource":"2022-07-16","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["degarelix"],"peptides":[{"slug":"degarelix","url":"https://peptidescanner.com/peptides/degarelix/"}]},"claims":[{"id":"headline","text":"Randomized Phase 2 Trial of Abiraterone Acetate Plus Prednisone, Degarelix, or the Combination in Men with Biochemically Recurrent Prostate Cancer After Radical Prostatectomy.","sourceIds":["pubmed-observation-pmid-34934969-2022-07-16-72492b30411d"]},{"id":"summary","text":"PubMed lists PMID 34934969 in European urology open science as Journal Article, with publication-date metadata of 2021-11-17 (day precision). PeptideScanner associated the retained record with the identity slug degarelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-34934969-2022-07-16-72492b30411d"]},{"id":"paragraph-1","text":"PubMed lists PMID 34934969 in European urology open science as Journal Article, with publication-date metadata of 2021-11-17 (day precision). PeptideScanner associated the retained record with the identity slug degarelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-34934969-2022-07-16-72492b30411d"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-34934969-2022-07-16-72492b30411d"]}],"sources":[{"id":"pubmed-observation-pmid-34934969-2022-07-16-72492b30411d","name":"PubMed","sourceClass":"A","title":"Randomized Phase 2 Trial of Abiraterone Acetate Plus Prednisone, Degarelix, or the Combination in Men with Biochemically Recurrent Prostate Cancer After Radical Prostatectomy. · retained source version 1:2022-07-16:current:72492b30411d7d89307e025851cc6b8fa3be1294cfb8d5192cf03509a9f56b25","url":"https://pubmed.ncbi.nlm.nih.gov/34934969/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"ef4e77e2e52966e66f535b3488f44d098e23e1ff25feb58466a0f3b99833d4dc","tierARecordSha256":"4c1188cc89db28f614e63d1b32db5f069764a92451c318bdbe12260a4f5b67fa"},"integrity":{"algorithm":"sha256","contentSha256":"32acd72e0c5ea3ddfb717f77b8ba27a735e6a41e64c5a7e0c84e7f6c796c2864"}},"pubmed-pmid-35069083-degarelix-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-35069083-degarelix:v1","objectPathId":"pubmed-pmid-35069083-degarelix-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-35069083-degarelix/","json":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-35069083-degarelix-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#pubmed-pmid-35069083-degarelix-v1"},"story":{"slug":"pubmed-pmid-35069083-degarelix","version":1,"domain":"Literature metadata","dateInSource":"2022-04-30","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["degarelix"],"peptides":[{"slug":"degarelix","url":"https://peptidescanner.com/peptides/degarelix/"}]},"claims":[{"id":"headline","text":"Patients and physician satisfaction of Degarelix in androgen deprivation therapy for advanced hormone-dependent prostate cancer in the Netherlands.","sourceIds":["pubmed-observation-pmid-35069083-2022-04-30-ecb2eb840f9e"]},{"id":"summary","text":"PubMed lists PMID 35069083 in Current urology as Journal Article, with publication-date metadata of 2021-06-25 (day precision). PeptideScanner associated the retained record with the identity slug degarelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-35069083-2022-04-30-ecb2eb840f9e"]},{"id":"paragraph-1","text":"PubMed lists PMID 35069083 in Current urology as Journal Article, with publication-date metadata of 2021-06-25 (day precision). PeptideScanner associated the retained record with the identity slug degarelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-35069083-2022-04-30-ecb2eb840f9e"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-35069083-2022-04-30-ecb2eb840f9e"]}],"sources":[{"id":"pubmed-observation-pmid-35069083-2022-04-30-ecb2eb840f9e","name":"PubMed","sourceClass":"A","title":"Patients and physician satisfaction of Degarelix in androgen deprivation therapy for advanced hormone-dependent prostate cancer in the Netherlands. · retained source version 1:2022-04-30:current:ecb2eb840f9e4cc5e056ab35bb29b20d1fee3e4e76b8b34ebb142ce28555deb9","url":"https://pubmed.ncbi.nlm.nih.gov/35069083/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"d7545108014122fdf5c859112cadfbe6aae1a5327aa86c887e6ffec280be3101","tierARecordSha256":"dff620b35be999df41c6d0b9a0af7ba24fb6dbb8760a916018253c87cc0a28d0"},"integrity":{"algorithm":"sha256","contentSha256":"b324b96f75a5d6e7f33fdc3678d29b02851d63023c5d395b6d997edbd7bd4048"}},"pubmed-pmid-35923949-degarelix-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-35923949-degarelix:v1","objectPathId":"pubmed-pmid-35923949-degarelix-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-35923949-degarelix/","json":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-35923949-degarelix-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#pubmed-pmid-35923949-degarelix-v1"},"story":{"slug":"pubmed-pmid-35923949-degarelix","version":1,"domain":"Literature metadata","dateInSource":"2025-10-31","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["degarelix"],"peptides":[{"slug":"degarelix","url":"https://peptidescanner.com/peptides/degarelix/"}]},"claims":[{"id":"headline","text":"Degarelix vs. leuprorelin for the treatment of prostate cancer in China: A cost-utility analysis.","sourceIds":["pubmed-observation-pmid-35923949-2025-10-31-3932cbbc6dee"]},{"id":"summary","text":"PubMed lists PMID 35923949 in Frontiers in public health as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2022-07-18 (day precision). PeptideScanner associated the retained record with the identity slug degarelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-35923949-2025-10-31-3932cbbc6dee"]},{"id":"paragraph-1","text":"PubMed lists PMID 35923949 in Frontiers in public health as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2022-07-18 (day precision). PeptideScanner associated the retained record with the identity slug degarelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-35923949-2025-10-31-3932cbbc6dee"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-35923949-2025-10-31-3932cbbc6dee"]}],"sources":[{"id":"pubmed-observation-pmid-35923949-2025-10-31-3932cbbc6dee","name":"PubMed","sourceClass":"A","title":"Degarelix vs. leuprorelin for the treatment of prostate cancer in China: A cost-utility analysis. · retained source version 1:2025-10-31:current:3932cbbc6deef0594557666de4e460945d20ba8f84d65faa389f5f95dd3b60cb","url":"https://pubmed.ncbi.nlm.nih.gov/35923949/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"1000dd3c20316132001b8b2085c67d93ff444d3212a72439658d58c8a2484a6c","tierARecordSha256":"969b967818c5d43473a022b28bcfdde53210005a2db5846c15dfb7be1a85e5be"},"integrity":{"algorithm":"sha256","contentSha256":"c43d63c1326d4d9fbd52828ec98317d42b2ea7e2bb77eec77953ba2debcda9e2"}},"pubmed-pmid-37455491-degarelix-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-37455491-degarelix:v1","objectPathId":"pubmed-pmid-37455491-degarelix-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-37455491-degarelix/","json":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-37455491-degarelix-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#pubmed-pmid-37455491-degarelix-v1"},"story":{"slug":"pubmed-pmid-37455491-degarelix","version":1,"domain":"Literature metadata","dateInSource":"2023-07-19","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["degarelix"],"peptides":[{"slug":"degarelix","url":"https://peptidescanner.com/peptides/degarelix/"}]},"claims":[{"id":"headline","text":"Investigation of the GnRH antagonist degarelix isomerization in biological matrices.","sourceIds":["pubmed-observation-pmid-37455491-2023-07-19-f0183ac2751a"]},{"id":"summary","text":"PubMed lists PMID 37455491 in Pharmacology research & perspectives as Journal Article, with publication-date metadata of 2023-08 (month precision). PeptideScanner associated the retained record with the identity slug degarelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-37455491-2023-07-19-f0183ac2751a"]},{"id":"paragraph-1","text":"PubMed lists PMID 37455491 in Pharmacology research & perspectives as Journal Article, with publication-date metadata of 2023-08 (month precision). PeptideScanner associated the retained record with the identity slug degarelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-37455491-2023-07-19-f0183ac2751a"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-37455491-2023-07-19-f0183ac2751a"]}],"sources":[{"id":"pubmed-observation-pmid-37455491-2023-07-19-f0183ac2751a","name":"PubMed","sourceClass":"A","title":"Investigation of the GnRH antagonist degarelix isomerization in biological matrices. · retained source version 1:2023-07-19:current:f0183ac2751ab7f21171bb646da537bfc46c0d5d04518783ac6c612481519a2a","url":"https://pubmed.ncbi.nlm.nih.gov/37455491/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"8c63a5afd09fa0edabf650ec050bb4e9188befe5b22fdbac2fb6b35969022fbb","tierARecordSha256":"8407f9c851121b6284f9dd883755ac2f990560f329b1c0fb679e1a569d935b7d"},"integrity":{"algorithm":"sha256","contentSha256":"4b1ac3a4b72ed19e519c5f9a088b3549048fd2d706c69a534f775269399110b7"}},"pubmed-pmid-38413843-degarelix-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-38413843-degarelix:v1","objectPathId":"pubmed-pmid-38413843-degarelix-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-38413843-degarelix/","json":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-38413843-degarelix-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#pubmed-pmid-38413843-degarelix-v1"},"story":{"slug":"pubmed-pmid-38413843-degarelix","version":1,"domain":"Literature metadata","dateInSource":"2026-07-24","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["degarelix"],"peptides":[{"slug":"degarelix","url":"https://peptidescanner.com/peptides/degarelix/"}]},"claims":[{"id":"headline","text":"Testosterone bounce predicts favorable prognoses for prostate cancer patients treated with degarelix.","sourceIds":["pubmed-observation-pmid-38413843-2026-07-24-ad0c3b1cf909"]},{"id":"summary","text":"PubMed lists PMID 38413843 in The Prostate as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2024-02-27 (day precision). PeptideScanner associated the retained record with the identity slug degarelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-38413843-2026-07-24-ad0c3b1cf909"]},{"id":"paragraph-1","text":"PubMed lists PMID 38413843 in The Prostate as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2024-02-27 (day precision). PeptideScanner associated the retained record with the identity slug degarelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-38413843-2026-07-24-ad0c3b1cf909"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-38413843-2026-07-24-ad0c3b1cf909"]}],"sources":[{"id":"pubmed-observation-pmid-38413843-2026-07-24-ad0c3b1cf909","name":"PubMed","sourceClass":"A","title":"Testosterone bounce predicts favorable prognoses for prostate cancer patients treated with degarelix. · retained source version 1:2026-07-24:current:ad0c3b1cf9096e39f738eb7f4769729d1290b536938f2be06a0c2e628d545711","url":"https://pubmed.ncbi.nlm.nih.gov/38413843/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"ca5a72dcf343cf2faee22a40d6f8d04833ec09a0db3ec8a369780944e1aa5e1d","tierARecordSha256":"ed339ceff2816d4da5326f67ff50b58062194764303d5da72b74699bdf8d4db2"},"integrity":{"algorithm":"sha256","contentSha256":"b6b9014cb881647b09a66fd9e6eb8f5c6b966d01d1eacb87169b510e796c964d"}},"pubmed-pmid-41918172-degarelix-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-41918172-degarelix:v1","objectPathId":"pubmed-pmid-41918172-degarelix-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-41918172-degarelix/","json":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-41918172-degarelix-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#pubmed-pmid-41918172-degarelix-v1"},"story":{"slug":"pubmed-pmid-41918172-degarelix","version":1,"domain":"Literature metadata","dateInSource":"2026-08-14","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["degarelix"],"peptides":[{"slug":"degarelix","url":"https://peptidescanner.com/peptides/degarelix/"}]},"claims":[{"id":"headline","text":"Resting state functional connectivity in paedophilic disorder and degarelix treatment.","sourceIds":["pubmed-observation-pmid-41918172-2026-08-14-c2b6c5686d40"]},{"id":"summary","text":"PubMed lists PMID 41918172 in Acta neuropsychiatrica as Journal Article, Randomized Controlled Trial, with publication-date metadata of 2026-04-01 (day precision). PeptideScanner associated the retained record with the identity slug degarelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-41918172-2026-08-14-c2b6c5686d40"]},{"id":"paragraph-1","text":"PubMed lists PMID 41918172 in Acta neuropsychiatrica as Journal Article, Randomized Controlled Trial, with publication-date metadata of 2026-04-01 (day precision). PeptideScanner associated the retained record with the identity slug degarelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-41918172-2026-08-14-c2b6c5686d40"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-41918172-2026-08-14-c2b6c5686d40"]}],"sources":[{"id":"pubmed-observation-pmid-41918172-2026-08-14-c2b6c5686d40","name":"PubMed","sourceClass":"A","title":"Resting state functional connectivity in paedophilic disorder and degarelix treatment. · retained source version 1:2026-08-14:current:c2b6c5686d4056539b6219afcdebd24e59cc635c423383db6870af5186a5f40f","url":"https://pubmed.ncbi.nlm.nih.gov/41918172/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"9e79695fcff6945e903c37476e57204f97e27c07e83da451a9eed282dbe5e9be","tierARecordSha256":"b237405d45f3893a49e21728dbf280b8e02c583c066d2ecf16ffdac3b4ae5031"},"integrity":{"algorithm":"sha256","contentSha256":"fb1269bdea47a7fd8a1db088f9a5ebca72f0e5d001e0b9cbbbd5b28d35ff45e5"}},"pubmed-pmid-41970125-degarelix-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-41970125-degarelix:v1","objectPathId":"pubmed-pmid-41970125-degarelix-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-41970125-degarelix/","json":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-41970125-degarelix-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#pubmed-pmid-41970125-degarelix-v1"},"story":{"slug":"pubmed-pmid-41970125-degarelix","version":1,"domain":"Literature metadata","dateInSource":"2026-08-13","sourceCheckedAt":"2026-11-15","publishedAt":"2026-11-15","peptideSlugs":["degarelix"],"peptides":[{"slug":"degarelix","url":"https://peptidescanner.com/peptides/degarelix/"}]},"claims":[{"id":"headline","text":"Fatal Interstitial Pneumonitis During Combined Degarelix, Darolutamide, and Docetaxel Therapy for Metastatic Prostate Cancer.","sourceIds":["pubmed-observation-pmid-41970125-2026-08-13-b35a1e4bcf50"]},{"id":"summary","text":"PubMed lists PMID 41970125 in Cureus as Case Reports, Journal Article, with publication-date metadata of 2026-03-10 (day precision). PeptideScanner associated the retained record with the identity slug degarelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-41970125-2026-08-13-b35a1e4bcf50"]},{"id":"paragraph-1","text":"PubMed lists PMID 41970125 in Cureus as Case Reports, Journal Article, with publication-date metadata of 2026-03-10 (day precision). PeptideScanner associated the retained record with the identity slug degarelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-41970125-2026-08-13-b35a1e4bcf50"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-41970125-2026-08-13-b35a1e4bcf50"]}],"sources":[{"id":"pubmed-observation-pmid-41970125-2026-08-13-b35a1e4bcf50","name":"PubMed","sourceClass":"A","title":"Fatal Interstitial Pneumonitis During Combined Degarelix, Darolutamide, and Docetaxel Therapy for Metastatic Prostate Cancer. · retained source version 1:2026-08-13:current:b35a1e4bcf506d66c521f8fa4cc5f80e65eb128079d70f2dabc1a0bcfe1a4658","url":"https://pubmed.ncbi.nlm.nih.gov/41970125/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"3d5e9fc86a9ebffbac9fa3cbe096ad2e6d48e2c4d3db19f7cbc69b703cd5b334","tierARecordSha256":"43a1e981802bcd87dc5eae6fa1922ef356a77ae81696e5e85a1c9859f1b1de46"},"integrity":{"algorithm":"sha256","contentSha256":"a5839deab4fc7bab75891cc4686e156cb89e4ed4923bb0ccfa66b437632c9acf"}},"pubmed-pmid-43041099-degarelix-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-43041099-degarelix:v1","objectPathId":"pubmed-pmid-43041099-degarelix-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-43041099-degarelix/","json":"https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-43041099-degarelix-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/degarelix.md#pubmed-pmid-43041099-degarelix-v1"},"story":{"slug":"pubmed-pmid-43041099-degarelix","version":1,"domain":"Literature metadata","dateInSource":"2026-11-17","sourceCheckedAt":"2026-11-17","publishedAt":"2026-11-17","peptideSlugs":["degarelix"],"peptides":[{"slug":"degarelix","url":"https://peptidescanner.com/peptides/degarelix/"}]},"claims":[{"id":"headline","text":"Development and Validation of a Stability-Indicating HPLC Method for Degarelix and Characterization of Its Degradation Impurities Using LC-MS, 1H NMR, and FTIR Techniques.","sourceIds":["pubmed-observation-pmid-43041099-2026-11-17-435b8b15458a"]},{"id":"summary","text":"PubMed lists PMID 43041099 in Biomedical chromatography : BMC as Journal Article, with publication-date metadata of 2027-01 (month precision). PeptideScanner associated the retained record with the identity slug degarelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-43041099-2026-11-17-435b8b15458a"]},{"id":"paragraph-1","text":"PubMed lists PMID 43041099 in Biomedical chromatography : BMC as Journal Article, with publication-date metadata of 2027-01 (month precision). PeptideScanner associated the retained record with the identity slug degarelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-43041099-2026-11-17-435b8b15458a"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-43041099-2026-11-17-435b8b15458a"]}],"sources":[{"id":"pubmed-observation-pmid-43041099-2026-11-17-435b8b15458a","name":"PubMed","sourceClass":"A","title":"Development and Validation of a Stability-Indicating HPLC Method for Degarelix and Characterization of Its Degradation Impurities Using LC-MS, 1H NMR, and FTIR Techniques. · retained source version 1:2026-11-17:current:435b8b15458aa919dd3758a413e19032c9f76b6b2bc81b65f4d46e0debb20935","url":"https://pubmed.ncbi.nlm.nih.gov/43041099/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"78be0f5abd9299e8014985137c43e29b6f31420206d9c3f1d317131e4e1a43cf","tierARecordSha256":"709357ae1603a43042813dcf265250144b32173130e1405afe86601da8e9cb8d"},"integrity":{"algorithm":"sha256","contentSha256":"48e923b4bc4a076fc1942e60af3fa9a76df45b2d959a07672b38d2363e5aef92"}}}}
